0001477932-18-003689.txt : 20180727 0001477932-18-003689.hdr.sgml : 20180727 20180727154521 ACCESSION NUMBER: 0001477932-18-003689 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 43 CONFORMED PERIOD OF REPORT: 20171231 FILED AS OF DATE: 20180727 DATE AS OF CHANGE: 20180727 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Madison Ventures Inc. CENTRAL INDEX KEY: 0001575975 STANDARD INDUSTRIAL CLASSIFICATION: METAL MINING [1000] IRS NUMBER: 000000000 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 333-188753 FILM NUMBER: 18974791 BUSINESS ADDRESS: STREET 1: 1810 E SAHARA AVE. STREET 2: SUITE 583 CITY: LAS VEGAS STATE: NV ZIP: 89104 BUSINESS PHONE: 866-239-0577 MAIL ADDRESS: STREET 1: 1810 E SAHARA AVE. STREET 2: SUITE 583 CITY: LAS VEGAS STATE: NV ZIP: 89104 10-Q 1 mdsv_10q.htm FORM 10-Q mdsv_10q.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(MARK ONE)

 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended: December 31, 2017

 

OR

 

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ____________ to ___________

 

Commission File No. 333-188753

 

MADISON VENTURES INC.

(Exact name of registrant as specified in its charter)

  

Nevada

 

None

(State or other jurisdiction of

 

(I.R.S. Employer

incorporation or organization)

 

Identification No.)

 

1810 E Sahara Ave Suite 583

Las Vegas, NV 89104

 (Address of principal executive offices, zip code)

 

(866) 239-0577

 (Registrant’s telephone number, including area code)

 

Indicate by check mark whether the issuer (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes o No x

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (check one):

 

Large accelerated filer

o

Accelerated filer

o

Non-accelerated filer

o

Smaller reporting company

x

(Do not check if a smaller reporting company)

 

Indicate by check mark whether the registrant is a shell company (as defined in Exchange Act Rule 12b-2 of the Exchange Act): Yes x No ¨

 

APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS DURING THE PRECEDING FIVE YEARS:

 

Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court. Yes o No o

 

APPLICABLE ONLY TO CORPORATE ISSUERS

 

As of July 20, 2018, there were 29,400,000 shares of common stock, $0.001 par value per share, outstanding.

 

 
 
 
 

 

MADISON VENTURES INC.

QUARTERLY REPORT ON FORM 10-Q

FOR THE PERIOD ENDED DECEMBER 31, 2017

 

INDEX 

 

Index

 

Page

 

Part I. Financial Information

 

Item 1.

Consolidated Financial Statements.

4

 

Condensed Consolidated Balance Sheets as of December 31, 2017 and March 31, 2017. (unaudited)

4

 

Condensed Consolidated Statements of Operations for the Three Months ended December 31, 2017 and 2016. (unaudited)

5

 

Condensed Consolidated Statements of Operations for the Nine Months ended December 31, 2017 and 2016. (unaudited).

6

 

Condensed Consolidated Statements of Changes in Stockholders Equity (Deficit) from March 31, 2016 to December 31, 2017. (unaudited)

7

 

Condensed Consolidated Statements of Cash Flows for the Nine Months ended December 31, 2017 and 2016. (unaudited)

8

 

Notes to the Condensed Consolidated Financial Statements. (unaudited)

9

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations.

15

 

Item 3.

Quantitative and Qualitative Disclosures About Market Risk.

16

 

Item 4.

Controls and Procedures.

16

 

Part II. Other Information

 

Item 1.

Legal Proceedings.

17

 

Item 1A.

Risk Factors.

17

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds.

17

 

Item 3.

Defaults Upon Senior Securities.

17

 

Item 4.

Mine Safety Disclosures.

17

 

Item 5.

Other Information.

17

 

Item 6.

Exhibits.

18

 

Signatures

19

 

 
2
 
 

  

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This Quarterly Report on Form 10-Q of Madison Ventures Inc., a Nevada corporation (the “Company”), contains “forward-looking statements,” as defined in the United States Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by terminology such as “may”, “will”, “should”, “could”, “expects”, “plans”, “intends”, “anticipates”, “believes”, “estimates”, “predicts”, “potential” or “continue” or the negative of such terms and other comparable terminology. These forward-looking statements include, without limitation, statements about our market opportunity, our strategies, competition, expected activities and expenditures as we pursue our business plan, and the adequacy of our available cash resources. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. Actual results may differ materially from the predictions discussed in these forward-looking statements. The economic environment within which we operate could materially affect our actual results. Additional factors are discussed in the Company’s filings with the Securities and Exchange Commission (“SEC”).

 

Our management has included projections and estimates in this Form 10-Q, which are based primarily on management’s experience in the industry, assessments of our results of operations, discussions and negotiations with third parties and a review of information filed by our competitors with the SEC or otherwise publicly available. We caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. We disclaim any obligation subsequently to revise any forward-looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.

 

 
3
 
Table of Contents

 

PART I. FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS. 

 

MADISON VENTURES INC.

Condensed Consolidated Balance Sheets (Unaudited)

 

 

 

December 31,

 

 

March 31,

 

 

 

2017

 

 

2017

 

 

 

 

 

 

 

 

ASSETS

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash

 

$ -

 

 

$ 8,639

 

Total assets

 

$ -

 

 

$ 8,639

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS' EQUITY (DEFICIT)

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

Accounts payable

 

$ 21,689

 

 

$ 77,274

 

Accrued liabilities

 

 

-

 

 

 

6,192

 

Due to related parties

 

 

251,842

 

 

 

236,942

 

Total current liabilities

 

 

273,531

 

 

 

320,408

 

Long-term liabilities:

 

 

 

 

 

 

 

 

Long-term debt due to related party

 

 

110,065

 

 

 

110,000

 

Total long-term liabilities

 

 

110,065

 

 

 

110,000

 

Total Liabilities

 

 

383,596

 

 

 

430,408

 

 

 

 

 

 

 

 

 

 

Commitments and Contingencies

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shareholders' equity (deficit):

 

 

 

 

 

 

 

 

Common stock: 300,000,000 shares authorized of $0.001 par value; 29,400,000 and 29,400,000 shares issued and outstanding as of December 31 and March 31, 2017, respectively

 

 

29,400

 

 

 

29,400

 

Additional paid-in capital

 

 

78,100

 

 

 

78,100

 

Accumulated deficit

 

 

(491,096 )

 

 

(515,531 )

Accumulated other comprehensive income (loss)

 

 

-

 

 

 

(13,738 )

Total shareholders’ equity (deficit)

 

 

(383,596 )

 

 

(421,769 )

Total liabilities and shareholders’ equity (deficit)

 

$ -

 

 

$ 8,639

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements

 

 
4
 
Table of Contents

  

MADISON VENTURES INC.

Condensed Consolidated Statements of Operations (Unaudited)

 

 

 

Three Months ended

December 31,

 

 

 

2017

 

 

2016

 

 

 

 

 

 

 

 

Operating costs:

 

 

 

 

 

 

Consulting and professional fees

 

$ 10,276

 

 

$ 8,507

 

Stock based compensation

 

 

-

 

 

 

-

 

Insurance

 

 

-

 

 

 

1

 

Gain on disposition of foreign subsidiary

 

 

-

 

 

 

-

 

Impairment of technology license

 

 

-

 

 

 

12,321

 

Other general & administrative expenses

 

 

15

 

 

 

4,561

 

Total operating costs

 

 

10,291

 

 

 

25,390

 

 

 

 

 

 

 

 

 

 

Other income (expense):

 

 

 

 

 

 

 

 

Foreign exchange gain (loss)

 

 

-

 

 

 

(5,649 )

Interest expense

 

 

-

 

 

 

(13 )

Total other income (expense)

 

 

-

 

 

 

(5,662 )

 

 

 

 

 

 

 

 

 

Net (loss)

 

$ (10,291 )

 

$ (31,052 )

 

 

 

 

 

 

 

 

 

(Loss) per common share:

 

 

 

 

 

 

 

 

Basic and diluted

 

$ (0.00 )

 

$ (0.00 )

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding:

 

 

 

 

 

 

 

 

Basic and diluted

 

 

29,400,000

 

 

 

29,400,000

 

 

 

 

 

 

 

 

 

 

Comprehensive income (loss):

 

 

 

 

 

 

 

 

Net (loss)

 

$ (10,291 )

 

$ (31,052 )

Other comprehensive income:

 

 

 

 

 

 

 

 

Foreign currency translation

 

 

-

 

 

 

3,377

 

 

 

 

 

 

 

 

 

 

Comprehensive (loss)

 

$ (10,291 )

 

$ (27,675 )

 

The accompanying notes are an integral part of these condensed consolidated financial statements

 

 
5
 
Table of Contents

  

MADISON VENTURES INC.

Condensed Consolidated Statements of Operations (Unaudited)

 

 

 

Nine Months ended

December 31,

 

 

 

2017

 

 

2016

 

 

 

 

 

 

 

 

Operating costs:

 

 

 

 

 

 

Consulting and professional fees

 

$ 23,661

 

 

$ 41,809

 

Stock based compensation

 

 

-

 

 

 

1,387

 

Insurance

 

 

-

 

 

 

2,551

 

Gain on disposition of foreign subsidiary, net of $13,738 foreign translation (loss) from prior periods

 

 

(48,911 )

 

 

-

 

Impairment of technology license

 

 

-

 

 

 

257,225

 

Other general & administrative expenses

 

 

815

 

 

 

11,953

 

Total operating costs

 

 

(24,435 )

 

 

314,925

 

 

 

 

 

 

 

 

 

 

Other income (expense):

 

 

 

 

 

 

 

 

Foreign exchange gain (loss)

 

 

-

 

 

 

(4,489

Interest expense

 

 

-

 

 

 

(13 )

Total other income (expense)

 

 

-

 

 

 

(4,502 )

 

 

 

 

 

 

 

 

 

Net income (loss)

 

$ 24,435

 

 

$ (319,427 )

 

 

 

 

 

 

 

 

 

Income (loss) per common share:

 

 

 

 

 

 

 

 

Basic and diluted

 

$ 0.00

 

 

$ (0.01 )

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding:

 

 

 

 

 

 

 

 

Basic and diluted

 

 

29,400,000

 

 

 

28,923,636

 

 

 

 

 

 

 

 

 

 

Comprehensive income (loss):

 

 

 

 

 

 

 

 

Net income (loss)

 

$ 24,435

 

 

$ (319,427 )

Other comprehensive income:

 

 

 

 

 

 

 

 

Foreign currency translation

 

 

-

 

 

 

3,155

 

 

 

 

 

 

 

 

 

 

Comprehensive income (loss)

 

$ 24,435

 

 

$ (316,272 )

 

The accompanying notes are an integral part of these condensed consolidated financial statements

 

 
6
 
Table of Contents

  

MADISON VENTURES INC.

Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit) (Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated

 

 

 

 

 

 

 

 

 

Common

 

 

Additional

 

 

 

 

 

other

 

 

 

 

 

 

Common

 

 

stock

 

 

paid-in

 

 

Accumulated

 

 

comprehensive

 

 

 

 

 

 

stock

 

 

amount

 

 

capital

 

 

deficit

 

 

Income (loss)

 

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, March 31, 2016

 

 

28,400,000

 

 

$ 28,400

 

 

$ 54,100

 

 

$ (194,669 )

 

$ (76 )

 

$ (112,245 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issuance for service

 

 

1,000,000

 

 

 

1,000

 

 

 

24,000

 

 

 

-

 

 

 

-

 

 

 

25,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Comprehensive loss, March 31, 2017

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(320,862 )

 

 

(13,662 )

 

 

(334,524 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, March 31, 2017

 

 

29,400,000

 

 

 

29,400

 

 

 

78,100

 

 

 

(515,531 )

 

 

(13,738 )

 

 

(421,769 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Disposition of foreign subsidiary

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

13,738

 

 

 

13,738

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income, December 31, 2017

 

 

-

 

 

 

-

 

 

 

-

 

 

 

24,435

 

 

 

-

 

 

 

24,435

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, December 31, 2017

 

 

29,400,000

 

 

$ 29,400

 

 

$ 78,100

 

 

$ (491,096 )

 

$ -

 

 

$ (383,596 )

 

Note: All share and per share information has been restated for all periods presented giving retroactive effect of the April 11, 2016 four to one forward stock split (see note 8).

 

The accompanying notes are an integral part of these condensed consolidated financial statements

 

 
7
 
Table of Contents

  

MADISON VENTURES INC.

Condensed Consolidated Statements of Cash Flows (Unaudited)

 

 

 

Nine Months Ended

December 31,

 

 

 

2017

 

 

2016

 

 

 

 

 

 

 

 

Cash flows from operating activities:

 

 

 

 

 

 

Net income (loss)

 

$ 24,435

 

 

$ (319,427 )

Adjustments to reconcile net loss to net cash (used in) provided by operating activities:

 

 

 

 

 

 

 

 

Employee stock based compensation

 

 

-

 

 

 

1,387

 

Impairment of technology license

 

 

-

 

 

 

257,225

 

(Gain) on disposition of foreign subsidiary

 

 

(48,911 )

 

 

-

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

Decrease in prepaid expenses

 

 

-

 

 

 

2,100

 

Decrease in miscellaneous receivable

 

 

-

 

 

 

4,792

 

Increase in accounts payable

 

 

6,964

 

 

 

50,629

 

Increase in accrued liabilities

 

 

(6,192 )

 

 

5,900

 

Net cash (used in) provided by operating activities

 

 

(23,704 )

 

 

2,606

 

 

 

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

Acquisition of technology license

 

 

-

 

 

 

(187,454 )

Net cash (used in) investing activities

 

 

-

 

 

 

(187,454 )

 

 

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

 

 

 

Proceeds from related parties

 

 

15,000

 

 

 

15,500

 

Proceeds from non-interest bearing term-debt

 

 

65

 

 

 

110,000

 

Net cash provided by financing activities

 

 

15,065

 

 

 

125,500

 

 

 

 

 

 

 

 

 

 

Effect of exchange rate changes on cash

 

 

-

 

 

 

3,725

 

 

 

 

 

 

 

 

 

 

Net (decrease) in cash

 

 

(8,639 )

 

 

(55,623 )

Cash, beginning of the year

 

 

8,639

 

 

 

66,795

 

Cash, end of the quarter

 

$ -

 

 

$ 11,172

 

 

 

 

 

 

 

 

 

 

Non-cash investing and financing activities

 

 

 

 

 

 

 

 

Shares issued for accrued compensation

 

$ -

 

 

$ 25,000

 

 

 

 

 

 

 

 

 

 

Supplement cash flow disclosure:

 

 

 

 

 

 

 

 

Interest paid

 

$ -

 

 

$ -

 

Income tax paid

 

$ -

 

 

$ -

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements

 

 
8
 
Table of Contents

  

MADISON VENTURES INC.

Notes to Condensed Consolidated Financial Statements (Unaudited)

As of December 31, 2017

 

1. Condensed financial statements

 

The accompanying unaudited condensed consolidated financial statements are presented in United States dollars and are prepared using the accrual method of accounting which conforms to generally accepted accounting principles in the United States of America (“US GAAP”) for interim financial reporting and the instructions for Form 10-Q pursuant to the rules and regulations of the Securities and Exchange Commission. Accordingly, they do not include all information and footnote disclosures necessary for a complete presentation of the financial position, results of operations, cash flows, and stockholders equity in conformity with generally accepted accounting principles. In the opinion of management, all adjustments considered necessary for a fair presentation of the results of operations and financial position have been included and all such adjustments are of a normal recurring nature.

 

The unaudited condensed consolidated balance sheet of the Company as of December 31, 2017, and the related consolidated balance sheet of the Company as of March 31, 2017, which is derived from the Company's audited financial statements, the unaudited condensed consolidated statement of operations and cash flows for the Nine Months ended December 31, 2017 and 2016 and the condensed consolidated statement of stockholders equity for the period of March 31, 2016 to December 31, 2017 and are included in this document. These unaudited condensed consolidated financial statements should be read in conjunction with the March 31, 2017 audited financial statements and related notes included in the Company’s most recent Form 10-K as filed with the Securities and Exchange Commission on March 20, 2018.

 

Operating results for the Nine Months ended December 31, 2017 are not necessarily indicative of the results that can be expected for the year ending March 31, 2018.

 

2. Nature of operations

 

Madison Ventures Inc. (“Company”) was incorporated in the State of Nevada as a for-profit company on September 14, 2009 and established a fiscal year end of March 31. The Company initially was engaged in the acquisition, exploration and development of natural resource properties. On February 27, 2015, the Company terminated the acquisition of the mineral claim and entered into a letter of intent with Ocure Ltd. (“Ocure”), pursuant to which the Company agreed to exclusively license certain technology from Ocure related to the development of products and devices for the treatment of anal fissures and on August 5, 2015, entered into an exclusive license agreement to Ocure’s semi-occlusive wound dressing for ambulatory treatment of acute and chronic anal fissures (the “Ocure License”). On July 9, 2015, the Company established the wholly-owned subsidiary Madison-IL Ltd., incorporated under the laws of the country of Israel to address the Company’s requirement for an Israeli company to operate and hold the assets associated with Ocure License. However, the Company has not made all payments required under the Ocure License and is in breach of that agreement. Ocure has not provided formal notice of termination. The License Agreement has not been extended or amended, and there was a substantial risk the agreement would be cancelled. Accordingly the investment in the technology license of $244,904, at September 30, 2016, is impaired and written off as a result of these circumstances. In a further step to exit this line of business due to Madison-IL not achieving the projected development milestones, the Company elected January 4, 2017 to terminate the Ocure License and write off the remaining investment. On April 1, 2017, by consent action of a majority of the Company’s shareholders, Madison Ventures sold Madison-IL, the wholly owned subsidiary, to a shareholder of the Company. See Note 4. The Company has no revenues, a limited operating history, and no current line of business.

 

The success of the Company is dependent upon the identification of products or services, the ability of the Company to obtain the necessary financing to develop such products or services, and upon future profitable operations.

 

Use of Estimates and Assumptions

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods presented. The Company is required to make judgments and estimates about the effect of matters that are inherently uncertain. The Company regularly evaluates estimates and assumptions related to the useful life and recoverability of long-lived assets, deferred income tax asset valuations and loss contingences. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. Although, we believe our judgments and estimates are appropriate, actual future results may be different; if different assumptions or conditions were to prevail, the results could be materially different from our reported results.

 

 
9
 
Table of Contents

 

MADISON VENTURES INC.

Notes to Condensed Consolidated Financial Statements (Unaudited)

As of December 31, 2017

 

2. Nature of operations (continued) 

 

Share-based Compensation

 

Codification topic 718 “Stock Compensation” requires that the cost resulting from all share-based transactions be recorded in the financial statements and establishes fair value as the measurement objective for share-based payment transactions with employees and acquired goods or services from non-employees. The codification also provides guidance on valuing and expensing these awards, as well as disclosure requirements of these equity arrangements. The Company adopted the codification upon creation of the company and will expense share based costs in the period incurred. The Company has not adopted a stock option plan or completed a share-based transaction; accordingly no stock-based compensation has been recorded to date.

 

Recent Accounting Pronouncements

 

The Company’s management has evaluated all the recently issued, but not yet effective, accounting standards that have been issued or proposed by the FASB or other standards-setting bodies through the filing date of these financial statements and does not believe the future adoption of any such pronouncements will have a material effect on the Company’s financial position and results of operations.

 

3. Going concern

 

These financial statements have been prepared on a going concern basis which assumes the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future. The Company has incurred losses since inception resulting in an accumulated deficit of approximately $491,000 as of December 31, 2017 and further losses are anticipated in the development of its business raising substantial doubt about the Company’s ability to continue as a going concern. The ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. The Company’s operating expenditure plan for the next fiscal year ending March 31, 2018 will require cash. Management intends to finance operating costs over the next twelve months with the issuance of common shares and/or related party borrowings.

 

4. Investment in technology license

 

On February 27, 2015, we entered into a letter of intent (the “Letter of Intent”) with Ocure Ltd. (“Ocure”), an Israeli corporation, pursuant to which the Company would be obligated to exclusively license certain technology from Ocure under terms of a license agreement to be negotiated between the Company and Ocure. The Letter of Intent terminated when the Company did not make the second required payment, however the Company continued to negotiate with Ocure. On August 5, 2015, as amended February 26, 2016, the company entered into an exclusive license agreement (the “License Agreement”) with Ocure and Madison-IL Ltd., a wholly-owned subsidiary of the Company incorporated in Israel on July 9, 2015 (the “Subsidiary”). Pursuant to the License Agreement, Ocure granted to the Subsidiary an exclusive, sub-licensable, worldwide, license (the “License”) to Ocure’s semi-occlusive wound dressing for ambulatory treatment of acute and chronic anal fissure, pursuant to Ocure’s patents and patent applications (the “Licensed Technology”) and to its production, use, import, offer for sale, sell, lease, distribute, or otherwise commercialize the Licensed Technology for uses classified as medical devices, or those otherwise approved ultimately as an OTC (over-the-counter) remedy. In a further step to exit this line of business due to Madison-IL not achieving the projected development milestones, the Company elected January 4, 2017 to terminate the Ocure License and write off the remaining investment. On April 1, 2017, by consent action of a majority of the Company’s shareholders, Madison Ventures sold Madison-IL, the wholly owned subsidiary, to a shareholder of the Company.

 

 
10
 
Table of Contents

 

MADISON VENTURES INC.

Notes to Condensed Consolidated Financial Statements (Unaudited)

As of December 31, 2017

 

4. Investment in technology license (continued)

 

Under the License Agreement, the Company was obligated as consideration for the Licensed Technology to provide the Subsidiary $250,000 for the commercialization of the Licensed Technology, payable according to the following schedule:

 

 

· $10,000 upon execution of the Letter of Intent (paid February 27, 2015 to Ocure),

 

· $90,000 at the later of May 11, 2015 or the final signing date of the License Agreement (the “Effective Date”),

 

· $50,000 on or before March 4, 2016, and

 

· $100,000 on or before April 8, 2016 (collectively, the “First $250,000 Tranche”).
 

The Effective Date occurred upon satisfaction of the Condition Precedent, as defined in the License Agreement, and approval of the Agreement by the Chief Scientist of the Israeli Ministry of the Economy. The License Agreement Effective Date is November 11, 2015; the date approval of the Chief Scientist of the Israeli Ministry of the Economy was received. Upon the 6-month anniversary of the Effective Date, if the Company had paid the First $250,000 Tranche, then Ocure would have transferred certain assets, as defined, to the Subsidiary, and the Company would be obligated to provide the Subsidiary a second $250,000 tranche, payable as follows:

 

 

· $100,000 on or before August 12, 2016,

 

· $100,000 on or before September 23, 2016, and

 

· $50,000 on or before October 28, 2016.
 

The License Agreement terminated, on a country-by-country basis, the later of: (a) the date of expiration of the last to expire of Ocure’s rights in Ocure Patents in such country or such other grant of statutory exclusivity, or (b) the end of a period of fifteen (15) years from the date of making the first commercial sale, as defined, in such country; unless sooner terminated pursuant to the terms of the License Agreement.

 

Immediately after the Effective Date of the License Agreement and for the period ending March 31, 2016 (as amended), the shareholders of Ocure and certain individuals designated by Ocure had the opportunity to purchase up to an aggregate of 7,100,000 (1,775,000 presplit) shares of the Company’s Common Stock at the par value of $0.001 per share. In addition, the Company was to establish an incentive stock option plan reserving up to 20% of the Company’s issued share capital, as of the closing. The right to purchase an aggregate of 7,100,000 (1,775,000 presplit) shares of the Company’s Common Stock expired unexercised and the Company has not established an incentive stock option plan.

 

In consideration of the license for the Licensed Technology and with respect to any inventions, improvement, development or enhancement based upon, consists of, comprises, contains or incorporates the Licensed Technology invented following the Effective Date by the Subsidiary, its affiliate or sub-licensee (the “New Inventions”), the Subsidiary agreed to pay Ocure royalties calculated as 5% of gross sales. In addition, the Subsidiary agreed to pay Ocure 20% of any cash or non-cash consideration received, whether for sublicense initiation fee, annual fee, sublicense milestone payments, or other such non-sale based royalty consideration payable by a sublicense as consideration for or under a sublicense.

 

The Company was in default of the First $250,000 Tranche aggregate payment due on April 8, 2016. Upon the six month anniversary of the Effective Date (May 11, 2016) no assets were transferred by Ocure to the Company’s subsidiary. As of March 31, 2017, the Company had advanced funds aggregating $221,850 to the Subsidiary and paid Ocure $10,000 under the License Agreement. As such, the Company was in breach of its obligations under the License Agreement, but had not received notice of termination from Ocure. Madison-IL had not achieved the projected development milestones and the Company elected January 4, 2017 to terminate the Ocure License.

 

 
11
 
Table of Contents

  

MADISON VENTURES INC.

Notes to Condensed Consolidated Financial Statements (Unaudited)

As of December 31, 2017

 

4. Investment in technology license (continued)

 

As of March 31, 2017, the Subsidiary in furtherance of the commercialization of the Licensed Technology has incurred an aggregate of $266,722 of costs recorded as the investment in technology license. At March 31, 2017, the additional costs recorded as the investment in technology license represent vendor obligations payable. In a further step to exit this line of business due to Madison-IL not achieving the projected development milestones, the Company elected January 4, 2017 to terminate the Ocure License and write off the remaining investment. On April 1, 2017, by consent action of a majority of the Company’s shareholders, Madison Ventures sold Madison-IL, the wholly owned subsidiary, to a shareholder of the Company.

 

Accordingly, the investment in the technology license of $266,722, at January 4, 2017, has been written off and recognized as an expense during the year ended March 31, 2017. As of December 31 and March 31, 2017, zero technology license costs are capitalized.

 

5. Due to related parties

 

Due to related parties at December 31 and March 31, 2017 consisted of the following:

 

 

 

December 31,

 

 

March 31,

 

 

 

2017

 

 

2017

 

 

 

 

 

 

 

 

Balance at beginning of period

 

$ 236,942

 

 

$ 213,442

 

Funds advanced

 

 

15,000

 

 

 

23,500

 

Funds repaid

 

 

(100

 

 

-

 

Balance at end of period

 

$ 251,842

 

 

$ 236,942

 

 

On July 3, July 8, July 10, August 12, November 12, November 13, 2014, January 23, February 27, March 5, May 16, June 17, June 30, July 6, August 13, November 17, 2015, February 13, February 20, March 7 and March 17, 2016, Ecogenics Limited, a shareholder of the Company, advanced the Company $2,000, $775, $1,460, $2,000, $2,000, $1,763, $2,000, $10,000, $3,525, $4,093, $2,755, $1,083, $5,000, $3,000, $2,041, $961, $5,000, $3,300, and $50,000 respectively, as a series of unsecured obligations.

 

On August 11 and November 10, 2016, Pompeii Finance, a shareholder of the Company, advanced the Company $6,500 and $5,250, respectively, as a series of unsecured obligations.

 

On April 1, 2017, by consent action of a majority of the Company’s shareholders, Madison Ventures negotiated the sale of Madison-IL, following the termination of the Ocure License, to Pompeii Finance for $100 which was deducted from the funds owed to Pompeii for the above advances. See Note 7.

 

The net funds aggregating $114,406 were used to pay operating costs of the Company. The aggregate obligations bear no interest, have no fixed term and are not evidenced by any written agreements. The shareholders are under no obligation to advance additional funds to the Company.

 

On December 3, December 24, 2015, January 4, January 6, January 15, November 10, 2016, February 7, March 30, and September 5, 2017, Morpheus Financial Corporation Limited, a shareholder of the Company, advanced the Company $37,473, $7,500, $7,326, $8,412, $49,975, $3,750, $5,000, $3,000, and $15,000, respectively, as a series of unsecured obligations. The funds aggregating $137,436 were used to pay operating costs of the Company. On February 7, and June 19, 2018, Morpheus advanced the Company $20,538 and $1,167, respectively, to pay operating costs of the Company.

 

On January 8, 2016, the aggregate advances received and future advances from Morpheus were structured as a noninterest bearing unsecured non-recourse loan due January 31, 2017. The shareholder, if requested by the Company, agreed to advance additional funds to the Company up to a maximum of $250,000 subject to certain timing limitation as defined. The Company is currently is negotiating an extension of the due date.

 

 
12
 
Table of Contents

 

MADISON VENTURES INC.

Notes to Condensed Consolidated Financial Statements (Unaudited)

As of December 31, 2017

 

6. Long-term debt due to related party

 

Long term debt at December 31 and March 31, 2017 consisted of the following:

 

 

 

December 31,

 

 

March 31,

 

 

 

2017

 

 

2017

 

 

 

 

 

 

 

 

Balance at beginning of period

 

$ 110,000

 

 

$ -

 

Funds advanced

 

 

65

 

 

 

110,000

 

Funds repaid

 

 

-

 

 

 

-

 

Balance at end of period

 

$ 110,065

 

 

$ 110,000

 

 

On April 18, 2016, the Company entered into a five year non-interest bearing loan agreement for $110,000 with Cronus Overseas Corporation, a shareholder of the Company. Proceeds were used to fund the Technology acquisition and operations. If the loan is not repaid on or before April 15, 2021 the loan amount will be subject to default interest on the amount then outstanding of ten percent (10%) per month during the first 30 days of delinquency, fifteen percent (15%) per month during the 31 to 60 days of delinquency, twenty percent (20%) per month during the 61 to 90 days of delinquency (the “Default Interest”). If the loan amount remains unpaid after 90 days the lender, at its option, will be entitled to a default payment of one hundred fifty-nine percent (159%) of the then outstanding loan amount inclusive of the Default Interest. On September 25, 2017, Cronus paid on behalf of the Company $65 for operating costs of the Company.

 

7. Related party transactions

 

Employment Agreements

 

On April 2, 2014, Mr. Gene Gregorio was appointed the Company’s President, Chief Executive Officer, Chief Financial Officer and sole Director. On April 20, 2014, the Company agreed to issue Mr. Gregorio 1,000,000 (250,000 presplit) restricted shares of the Company’s Common Stock, valued at $25,000, based on the market close, as compensation for his services for an initial term of one year (the “April 20th Agreement”). On March 31, 2015, the Company issued Mr. Gregorio the agreed 1,000,000 restricted shares of the Company’s Common Stock.

 

In addition, if during the term of the April 20th Agreement Mr. Gregorio’s direct efforts result in a consummated financing for the Company he shall be paid a 5.0% fee on such financing received by the Company, at his option, as either cash or shares of Company’s Common Stock at the offering price. Additionally, the Company will grant Mr. Gregorio a 2 year stock option priced at the current market trading price equal to 5% of the aggregate shares issued to investors within the financing

 

On April 14, 2015, the April 20th Agreement with Mr. Gene Gregorio was extended for a second year under the same terms and conditions. Mr. Gregorio will be issued 1,000,000 restricted shares of the Company’s Common Stock, valued at $25,000, based on the market close, as compensation for his services for the second year the extended April 20th Agreement.

 

On August 9, 2016, the Company issued Mr. Gregorio the agreed 1,000,000 restricted shares of the Company’s Common Stock for services rendered during the period April 21, 2015 to April 20, 2016.

 

On April 23, 2018, Mr. Gregorio resigned as the Company’s President, Chief Executive Officer, Chief Financial Officer and as the sole Director.

 

Madison-IL

 

On March 31, 2017, the Company forgave the intercompany debt between Madison Ventures, Inc. and Madison-IL Ltd which aggregated $231,850. The Company, established Madison-IL on July 9, 2015 as a wholly-owned subsidiary, incorporated under the laws of the country of Israel to address the Company’s requirement for an Israeli company to operate and hold the assets associated with Ocure License. Following the Company’s January 4, 2017 decision to terminate the Ocure License and to dissolve or liquidate Madison-IL, by consent action of a majority of the Company’s shareholders, Madison Ventures negotiated the sale of Madison-IL to Pompeii Finance, a shareholder of the Company, on April 1, 2017 for $100 which was deducted from the funds owed to Pompeii for related party advances. See Note 5. Pompeii assumes the remaining assets and liabilities of Madison-IL which on March 31, 2017 aggregated 23,844 NIL and 250,996 NIL or approximately $6,566 and $69,115, respectively. On April 1, 2017, the Company recognized a net gain from the sale of Madison-IL of $48,911 ($62,549 of net liabilities eliminated, offset by $13,738 of other comprehensive losses from prior period foreign translation adjustments and $100 of proceeds received).

 

 
13
 
Table of Contents

 

MADISON VENTURES INC.

Notes to Condensed Consolidated Financial Statements (Unaudited)

As of December 31, 2017

 

8. Capital stock

 

The Company’s capitalization is 300,000,000 shares of common stock, with a par value of $0.001 per share, with 29,400,000 shares issued and outstanding at December 31, 2017 and March 31, 2017. On April 11, 2016, the Company effected a four for one forward stock split of our i) authorized and ii) issued and outstanding shares of common stock. All share information has been restated for all periods presented giving retroactive effect of the April 11, 2016 four to one forward stock split. Prior to the forward stock split the Company had 75,000,000 authorized shares of common stock, with a par value of $0.001 per share and 7,100,000 shares issued and outstanding at March 31, 2016.

 

As of March 31, 2017 and 2016, the Company has not granted any stock options or stock warrants.

 

9. Subsequent Events

 

On February 7, 2018, Morpheus Financial Corporation Limited, a shareholder of the Company, advanced the Company $20,538 (advanced as 25,735 CND) to pay operating costs.

 

On April 23, 2018, the Company entered into a Plan of Reorganization and Agreement of Securities Exchange (the “Agreement”) with Firetainment Inc. (“Firetainment”), a Florida Corporation. The Agreement will result in the merger of Firetainment into Madison Ventures with the corporation to survive as Firetainment Inc. Pursuant to the Agreement the Company agreed to issue Firetainment two hundred million (200,000,000) common shares in exchange for all of the shares of Firetainment. This issuance will result in a change in control of the Company. Under the Agreement, upon execution, Firetainment received the immediate right to the appointment of the directors and officers of the surviving corporation by the resignation of the existing sole director and officer of the Company and the simultaneous appointment of its own designee being the newly appointed sole director and officer. The closing of the Agreement will take place upon the delivery and completion of Firetainment audited statements for the period ending March 31, 2018, unless another time or date, or both, are agreed to in writing by the parties.

 

Also on April 23, 2018, the Board of Directors appointed William Shawn Clark as our Chief Executive Officer, Chief Financial Officer, Secretary and Treasurer as well as our Sole Director. Concurrent with Mr. Clarks’ appointment, Eugenio Gregorio resigned as Chief Executive Officer, Chief Financial Officer, Secretary and Treasurer as well as our Sole Director. Mr. Clark, the sole owner of Firetainment, is now our sole officer and director.

 

On June 19, 2018, Morpheus Financial Corporation Limited, a shareholder of the Company, advanced the Company $1,167 to pay operating costs.

 

On June 29, 2018, Firetainment Inc. advanced the Company $10,000 to pay operating costs.

 

On July 5, 2018, holders of 15,820,000 shares of the Company’s outstanding common stock, representing approximately 53.8% of the outstanding shares, approved, by written consents, an amendment to the articles of incorporation of the Company to change the name of the Company from “Madison Ventures Inc.” to “Viabuilt Ventures Inc.” On July 5, 2018, there were no written consents received by the Company representing a vote against, abstention or broker non-vote with respect to the proposal to change the name. The Company expects to change its name when all regulatory approvals have been obtained.

 

 
14
 
Table of Contents

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

 

The following information should be read in conjunction with (i) the financial statements of Madison Ventures Inc., a Nevada corporation (the “Company”), an development stage company, and the notes thereto appearing elsewhere in this Form 10-Q together with (ii) the more detailed business information and the December 31, 2017 audited financial statements and related notes included in the Company’s Form 10-K (File No. 333-188753; the “Form 10-K”), as filed with the Securities and Exchange Commission on March 20, 2018. Statements in this section and elsewhere in this Form 10-Q that are not statements of historical or current fact constitute “forward-looking” statements

 

OVERVIEW

 

The Company was incorporated in the State of Nevada on September 14, 2009 and established a fiscal year end of March 31. It is a development-stage company.

 

During early 2015, we decided to abandon our mineral exploration properties and on February 27, 2015, we entered into a letter of intent with Ocure, pursuant to which we agreed to exclusively license certain technology from Ocure related to the development of products and devices for the treatment of anal fissures under terms of a license agreement.

 

Under the License Agreement, the Company was obligated as consideration for the Licensed Technology to make certain payments. As of December 31, 2017 and March 31, 2017, the Company had advanced $221,850 to the Subsidiary and paid Ocure $10,000 in furtherance of the commercialization of the Licensed Technology. Effective January 4, 2017, the Company determined to terminate all aspects of the Ocure License and to write off any investment made. On April 1, 2017, the Company sold all the shares of its Israeli subsidiary and obtained majority shareholder consent to do so, as the Israeli subsidiary comprised substantially all of the assets of the Company.

 

The Company is now seeking new business opportunities.

 

GOING CONCERN

 

To date the Company has little operations or revenues and consequently has incurred recurring losses from operations. No revenues are anticipated until we complete the financing we endeavor to obtain, as described in the Form 10-K, and implement our business plan. The ability of the Company to continue as a going concern is dependent on raising capital to fund our business plan and ultimately to attain profitable operations. Accordingly, these factors raise substantial doubt as to the Company’s ability to continue as a going concern.

 

The Company plans to raise additional funds through debt or equity offerings. There is no guarantee that the Company will be able to raise any capital through this or any other offerings.

 

PLAN OF OPERATION

 

The Company is now seeking new business opportunities.

 

RESULTS OF OPERATIONS

 

Nine-Months Ended December 31, 2017 and 2016

 

We recorded no revenues for the nine months ended December 31, 2017 and 2016. However, we recorded a gain on the sale of a foreign subsidiary of $48,911 during the nine months ended December 31, 2017. The net gain from the sale of Madison-IL was a result of net liabilities eliminated, offset by $13,738 of other comprehensive losses from prior period foreign translation adjustments and $100 of proceeds received from a shareholder of the Company.

 

 
15
 
Table of Contents

 

For the nine months ended December 31, 2017, total operating costs were $(24,435), consisting of consulting and professional fees of $23,661 and $815 in other general and administrative expenses, offset by a gain on the sale of a foreign subsidiary of $48,911. By comparison, for the nine months ended December 31, 2016, total operating costs were $314,925, consisting of $41,809 of consulting and professional fees, $1,387 of stock based compensation, $2,551 of insurance, $257,225 of impairment on our technology license, and $11,953 in other general and administrative expenses.

 

We had net income of $24,435 and net losses of $(319,427) during the nine months ended December 31, 2017 and December 31, 2016, respectively. The net income during the nine months ended December 31, 2017 was primarily due to the sale of our foreign subsidiary.

 

Liquidity and Capital Resources

 

At December 31, 2017, we had a cash balance of nil, total current liabilities of approximately $383,596 and working capital deficit of $383,596 and a stockholders’ deficit of approximately $383,596. We do not have sufficient cash on hand to fund our ongoing operational expenses. We will need to raise funds to commence fund our ongoing operational expenses. Additional funding will likely come from equity financing from the sale of our common. If we are successful in completing an equity financing, existing shareholders will experience dilution of their interest in our Company. We do not have any financing arranged and we cannot provide investors with any assurance that we will be able to raise sufficient funding from the sale of our common stock to fund ongoing operational expenses. In the absence of such financing, our business will likely fail. There are no assurances that we will be able to achieve further sales of our common stock or any other form of additional financing. If we are unable to achieve the financing necessary to continue our plan of operations, then we will not be able to continue our operations and our business will fail.

 

Off balance sheet arrangements

 

We have no off-balance sheet arrangements.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

 

As a smaller reporting company (as defined in Rule 12b-2 of the Exchange Act), we are not required to provide the information called for by this Item 3.

 

ITEM 4. CONTROLS AND PROCEDURES.

 

DISCLOSURE CONTROLS AND PROCEDURES

 

Under the supervision and with the participation of our management, our principal executive officer and principal financial officer, who are the same person, are responsible for conducting an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as of the end of the fiscal quarter covered by this report. Disclosure controls and procedures means that the material information required to be included in our Securities and Exchange Commission reports is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms relating to our company, including any consolidating subsidiaries, and was made known to us by others within those entities, particularly during the period when this report was being prepared. Based on this evaluation, our principal executive officer and principal financial officer concluded as of the evaluation date that our disclosure controls and procedures were not effective as of December 31, 2017.

 

There were no changes in the Company’s internal controls over financial reporting during the most recently completed fiscal quarter that have materially affected or are reasonably likely to materially affect the Company’s internal control over financial reporting.

 

 
16
 
Table of Contents

 

PART II. OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS.

 

The Company is not currently subject to any legal proceedings. From time to time, the Company may become subject to litigation or proceedings in connection with its business, as either a plaintiff or defendant. There are no such pending legal proceedings to which the Company is a party that, in the opinion of management, is likely to have a material adverse effect on the Company’s business, financial condition or results of operations.

 

ITEM 1A. RISK FACTORS

 

As a smaller reporting company (as defined in Rule 12b-2 of the Exchange Act), we are not required to provide the information called for by this Item 1A.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

 

None.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES.

 

None.

 

ITEM 5. OTHER INFORMATION.

 

None.

 

 
17
 
Table of Contents

 

ITEM 6. EXHIBITS.

 

(a) Exhibits required by Item 601 of Regulation SK.

 

Number

 

Description

 

3.1

 

Articles of Incorporation (1)

 

3.2

 

Bylaws (1)

 

31.1

 

Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

31.2

 

Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

32.1

 

Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

101.INS *

 

XBRL Instance Document

 

101.SCH *

 

XBRL Taxonomy Extension Schema Document

 

101.CAL *

 

XBRL Taxonomy Extension Calculation Linkbase Document

 

101.DEF *

 

XBRL Taxonomy Extension Definition Linkbase Document

 

101.LAB *

 

XBRL Taxonomy Extension Label Linkbase Document

 

101.PRE *

 

XBRL Taxonomy Extension Presentation Linkbase Document

_____________________

(1) Filed and incorporated by reference to the Company’s Registration Statement on Form S-1 (File No. 333 - 188753), as filed with the Securities and Exchange Commission on May 22, 2013.

 

* XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.

 

 
18
 
Table of Contents

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

 

MADISON VENTURES INC.

 

(Name of Registrant)

 

Date: July 27, 2018

By:

/s/ William Shawn Clark

 

 

Name:

William Shawn Clark

 

 

Title:

President, Secretary, and Treasurer
(principal executive officer,

principal financial officer,
and principal accounting officer)

 

 

 
19
 
Table of Contents

  

EXHIBIT INDEX

 

Number

 

Description

 

3.1

 

Articles of Incorporation (1)

 

3.2

 

Bylaws (1)

 

31.1

 

Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

31.2

 

Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

32.1

 

Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

101.INS *

 

XBRL Instance Document

 

101.SCH *

 

XBRL Taxonomy Extension Schema Document

 

101.CAL *

 

XBRL Taxonomy Extension Calculation Linkbase Document

 

101.DEF *

 

XBRL Taxonomy Extension Definition Linkbase Document

 

101.LAB *

 

XBRL Taxonomy Extension Label Linkbase Document

 

101.PRE *

 

XBRL Taxonomy Extension Presentation Linkbase Document

 __________________

(1) Filed and incorporated by reference to the Company’s Registration Statement on Form S-1 (File No. 333-188753), as filed with the Securities and Exchange Commission on May 22, 2013.

 

* XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.

 

 

20
 

EX-31.1 2 mdsv_ex311.htm CERTIFICATION mdsv_ex311.htm

EXHIBIT 31.1

 

SECTION 302 CERTIFICATION OF
PRINCIPAL EXECUTIVE OFFICER OF MADISON VENTURES INC.

 

I, William Shawn Clark, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Madison Ventures Inc.;

 

 

2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

 

 

3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

 

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a–15(e) and 15d–15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and have:

 

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

 

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

 

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

 

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

 

 

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

Date: July 27, 2018

By:

/s/ William Shawn Clark

 

 

 

William Shawn Clark

 

 

 

President, Secretary, and Treasurer

 

 

 

(principal executive officer, principal financial officer,
and principal accounting officer)

 

 

EX-31.2 3 mdsv_ex312.htm CERTIFICATION mdsv_ex312.htm

EXHIBIT 31.2

 

SECTION 302 CERTIFICATION OF

PRINCIPAL FINANCIAL OFFICER OF MADISON VENTURES INC.

 

I, William Shawn Clark, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Madison Ventures Inc.;

 

 

2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

 

 

3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

 

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a–15(e) and 15d–15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and have:

   

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

 

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

 

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

 

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

 

 

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

Date: July 27, 2018

By: 

/s/ William Shawn Clark

 

 

 

William Shawn Clark

 

 

 

President, Secretary, and Treasurer

 

 

 

(principal executive officer, principal financial officer,
and principal accounting officer)

 

 

EX-32.1 4 mdsv_ex321.htm CERTIFICATION mdsv_ex321.htm

EXHIBIT 32.1

 

SECTION 906 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND

PRINCIPAL FINANCIAL OFFICER OF MADISON VENTURES INC.

 

In connection with the accompanying Quarterly Report on Form 10-Q of Madison Ventures Inc. for the quarter ended December 31, 2017, the undersigned, William Shawn Clark, President of Madison Ventures Inc., does hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

 

(1) such Quarterly Report on Form 10-Q for the quarter ended December 31, 2017 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

 

 

 

(2) the information contained in such Quarterly Report on Form 10-Q for the quarter ended December 31, 2017 fairly presents, in all material respects, the financial condition and results of operations of Madison Ventures Inc.

 

 

Date: July 27, 2018

By: 

/s/ William Shawn Clark

 

 

 

William Shawn Clark

 

 

 

President, Secretary, and Treasurer

 

 

 

(principal executive officer, principal financial officer,
and principal accounting officer)

 

 

EX-101.INS 5 mdsv-20171231.xml XBRL INSTANCE DOCUMENT 0001575975 2017-04-01 2017-12-31 0001575975 2017-03-31 0001575975 2017-12-31 0001575975 2018-07-20 0001575975 us-gaap:CommonStockMember 2016-03-31 0001575975 us-gaap:AdditionalPaidInCapitalMember 2016-03-31 0001575975 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-03-31 0001575975 us-gaap:RetainedEarningsMember 2016-03-31 0001575975 2016-04-01 2016-09-30 0001575975 2016-10-01 2016-12-31 0001575975 mdsv:ForwardStockSplitMember 2016-03-31 0001575975 mdsv:ForwardStockSplitMember 2016-04-01 2016-04-11 0001575975 mdsv:MrGregorioMember 2016-08-01 2016-08-09 0001575975 mdsv:MrGeneGregorioMember 2014-04-02 2014-04-20 0001575975 mdsv:MrGeneGregorioMember 2015-03-01 2015-03-31 0001575975 mdsv:MrGeneGregorioMember 2014-04-01 2014-04-20 0001575975 mdsv:MrGeneGregorioMember 2015-04-02 2015-04-14 0001575975 mdsv:CronusOverseasCorporationMember 2016-04-18 0001575975 mdsv:CronusOverseasCorporationMember 2016-04-01 2016-04-18 0001575975 mdsv:EcogenicsLimitedMember 2014-07-03 0001575975 mdsv:EcogenicsLimitedMember 2014-07-08 0001575975 mdsv:EcogenicsLimitedMember 2014-07-10 0001575975 mdsv:EcogenicsLimitedMember 2014-08-12 0001575975 mdsv:EcogenicsLimitedMember 2014-11-12 0001575975 mdsv:EcogenicsLimitedMember 2014-11-13 0001575975 mdsv:EcogenicsLimitedMember 2015-01-23 0001575975 mdsv:EcogenicsLimitedMember 2015-02-27 0001575975 mdsv:EcogenicsLimitedMember 2015-03-05 0001575975 mdsv:EcogenicsLimitedMember 2015-05-16 0001575975 mdsv:EcogenicsLimitedMember 2015-06-17 0001575975 mdsv:EcogenicsLimitedMember 2015-06-30 0001575975 mdsv:EcogenicsLimitedMember 2015-07-06 0001575975 mdsv:EcogenicsLimitedMember 2015-08-13 0001575975 mdsv:EcogenicsLimitedMember 2015-11-17 0001575975 mdsv:EcogenicsLimitedMember 2016-02-13 0001575975 mdsv:EcogenicsLimitedMember 2016-02-20 0001575975 mdsv:EcogenicsLimitedMember 2016-03-07 0001575975 mdsv:EcogenicsLimitedMember 2016-03-17 0001575975 mdsv:PompeiiFinanceMember 2016-08-11 0001575975 mdsv:PompeiiFinanceMember 2016-11-10 0001575975 mdsv:MorpheusFinancialCorporationLimitedMember 2015-12-03 0001575975 mdsv:MorpheusFinancialCorporationLimitedMember 2015-12-24 0001575975 mdsv:MorpheusFinancialCorporationLimitedMember 2016-01-04 0001575975 mdsv:MorpheusFinancialCorporationLimitedMember 2016-01-06 0001575975 mdsv:MorpheusFinancialCorporationLimitedMember 2016-01-15 0001575975 mdsv:MorpheusFinancialCorporationLimitedMember 2016-11-10 0001575975 mdsv:MorpheusFinancialCorporationLimitedMember 2017-03-31 0001575975 us-gaap:LicenseAgreementTermsMember 2017-03-31 0001575975 2016-04-08 0001575975 us-gaap:CommonStockMember 2016-04-01 2017-03-31 0001575975 us-gaap:CommonStockMember 2017-03-31 0001575975 us-gaap:AdditionalPaidInCapitalMember 2016-04-01 2017-03-31 0001575975 us-gaap:AdditionalPaidInCapitalMember 2017-03-31 0001575975 us-gaap:RetainedEarningsMember 2016-04-01 2017-03-31 0001575975 us-gaap:RetainedEarningsMember 2017-03-31 0001575975 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-04-01 2017-03-31 0001575975 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-03-31 0001575975 2016-04-01 2016-12-31 0001575975 2016-12-31 0001575975 us-gaap:LicenseAgreementTermsMember 2016-03-31 0001575975 mdsv:MorpheusFinancialCorporationLimitedMember 2017-02-07 0001575975 mdsv:MorpheusFinancialCorporationLimitedMember 2017-03-30 0001575975 mdsv:MorpheusFinancialCorporationLimitedMember 2017-09-05 0001575975 mdsv:MorpheusFinancialCorporationLimitedMember us-gaap:SubsequentEventMember 2018-02-07 0001575975 mdsv:PompeiiFinanceMember mdsv:MadisonILLtdMember 2017-03-31 0001575975 2016-03-31 0001575975 2016-04-01 2017-03-31 0001575975 us-gaap:SubsequentEventMember mdsv:SecuritiesExchangeAgreementMember mdsv:FiretainmentIncMember 2018-04-03 2018-04-23 0001575975 us-gaap:LicenseAgreementTermsMember 2015-04-01 2016-03-31 0001575975 mdsv:MadisonVenturesIncMember mdsv:MadisonILLtdMember 2016-04-01 2017-03-31 0001575975 2017-10-01 2017-12-31 0001575975 mdsv:PompeiiFinanceMember mdsv:AprilOneTwoThousandSeventeenMember 2017-12-31 0001575975 mdsv:PompeiiFinanceMember mdsv:MadisonILLtdMember mdsv:AprilOneTwoThousandSeventeenMember 2017-04-01 2017-12-31 0001575975 mdsv:PompeiiFinanceMember mdsv:MadisonILLtdMember mdsv:AprilOneTwoThousandSeventeenMember 2017-12-31 0001575975 us-gaap:LicenseAgreementTermsMember 2016-04-01 2017-03-31 0001575975 us-gaap:CommonStockMember 2017-04-01 2017-12-31 0001575975 us-gaap:CommonStockMember 2017-12-31 0001575975 us-gaap:AdditionalPaidInCapitalMember 2017-04-01 2017-12-31 0001575975 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001575975 us-gaap:RetainedEarningsMember 2017-04-01 2017-12-31 0001575975 us-gaap:RetainedEarningsMember 2017-12-31 0001575975 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-04-01 2017-12-31 0001575975 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0001575975 mdsv:MorpheusFinancialCorporationLimitedMember us-gaap:SubsequentEventMember 2018-06-19 0001575975 mdsv:FiretainmentIncMember us-gaap:SubsequentEventMember 2018-06-29 0001575975 us-gaap:SubsequentEventMember 2018-07-05 0001575975 us-gaap:SubsequentEventMember 2018-07-01 2018-07-05 0001575975 us-gaap:LicenseAgreementTermsMember 2017-04-01 2017-12-31 0001575975 us-gaap:LicenseAgreementTermsMember 2017-12-31 0001575975 mdsv:LicenseAgreementTermsOneMember 2017-04-01 2017-12-31 0001575975 mdsv:EcogenicsLimitedMember 2017-12-31 0001575975 mdsv:CronusOverseasCorporationMember 2017-09-01 2017-09-25 0001575975 mdsv:LicenseAgreementTermsOneMember 2017-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure Madison Ventures Inc. 0001575975 10-Q 2017-12-31 false --03-31 No No No Smaller Reporting Company Q3 2018 236942 251842 2000 775 1460 2000 2000 1763 2000 10000 3525 4093 2755 1083 5000 3000 2041 961 5000 3300 50000 6500 5250 37473 7500 7326 8412 49975 3750 137436 5000 3000 15000 20538 213442 1167 10000 114406 29400000 0.001 0.001 0.001 0.001 300000000 300000000 75000000 29400000 29400000 7100000 29400000 29400000 7100000 15820000 -421769 -383596 28400 54100 -76 -194669 29400 78100 -515531 -13738 -112245 29400 78100 -491096 24435 -27675 -320862 -13662 -316272 -334524 -10291 24435 28400000 29400000 29400000 -13738 13378 430408 383596 62549 1000000 1000000 <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Madison Ventures Inc. (&#8220;Company&#8221;) was incorporated in the State of Nevada as a for-profit company on September 14, 2009 and established a fiscal year end of March 31. The Company initially was engaged in the acquisition, exploration and development of natural resource properties. On February 27, 2015, the Company terminated the acquisition of the mineral claim and entered into a letter of intent with Ocure Ltd. (&#8220;Ocure&#8221;), pursuant to which the Company agreed to exclusively license certain technology from Ocure related to the development of products and devices for the treatment of anal fissures and on August 5, 2015, entered into an exclusive license agreement to Ocure&#8217;s semi-occlusive wound dressing for ambulatory treatment of acute and chronic anal fissures (the &#8220;Ocure License&#8221;). On July 9, 2015, the Company established the wholly-owned subsidiary Madison-IL Ltd., incorporated under the laws of the country of Israel to address the Company&#8217;s requirement for an Israeli company to operate and hold the assets associated with Ocure License. However, the Company has not made all payments required under the Ocure License and is in breach of that agreement. Ocure has not provided formal notice of termination. The License Agreement has not been extended or amended, and there was a substantial risk the agreement would be cancelled. Accordingly the investment in the technology license of $244,904, at September 30, 2016, is impaired and written off as a result of these circumstances. In a further step to exit this line of business due to Madison-IL not achieving the projected development milestones, the Company elected January 4, 2017 to terminate the Ocure License and write off the remaining investment. On April 1, 2017, by consent action of a majority of the Company&#8217;s shareholders, Madison Ventures sold Madison-IL, the wholly owned subsidiary, to a shareholder of the Company. See Note 4. The Company has no revenues, a limited operating history, and no current line of business.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The success of the Company is dependent upon the identification of products or services, the ability of the Company to obtain the necessary financing to develop such products or services, and upon future profitable operations.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><u>Use of Estimates and Assumptions</u></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods presented. The Company is required to make judgments and estimates about the effect of matters that are inherently uncertain. The Company regularly evaluates estimates and assumptions related to the useful life and recoverability of long-lived assets, deferred income tax asset valuations and loss contingences. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. Although, webelieve our judgments and estimates are appropriate, actual future results may be different; if different assumptions or conditions were to prevail, the results could be materially different from our reported results.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><u>Share-based Compensation</u></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Codification topic 718 &#8220;Stock Compensation&#8221; requires that the cost resulting from all share-based transactions be recorded in the financial statements and establishes fair value as the measurement objective for share-based payment transactions with employees and acquired goods or services from non-employees. The codification also provides guidance on valuing and expensing these awards, as well as disclosure requirements of these equity arrangements. The Company adopted the codification upon creation of the company and will expense share based costs in the period incurred. The Company has not adopted a stock option plan or completed a share-based transaction; accordingly no stock-based compensation has been recorded to date.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><u>Recent Accounting Pronouncements</u></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The Company&#8217;s management has evaluated all the recently issued, but not yet effective, accounting standards that have been issued or proposed by the FASB or other standards-setting bodies through the filing date of these financial statements and does not believe the future adoption of any such pronouncements will have a material effect on the Company&#8217;s financial position and results of operations.</font></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On February 27, 2015, we entered into a letter of intent (the &#8220;Letter of Intent&#8221;) with Ocure Ltd. (&#8220;Ocure&#8221;), an Israeli corporation, pursuant to which the Company would be obligated to exclusively license certain technology from Ocure under terms of a license agreement to be negotiated between the Company and Ocure. The Letter of Intent terminated when the Company did not make the second required payment, however the Company continued to negotiate with Ocure. On August 5, 2015, as amended February 26, 2016, the company entered into an exclusive license agreement (the &#8220;License Agreement&#8221;) with Ocure and Madison-IL Ltd., a wholly-owned subsidiary of the Company incorporated in Israel on July 9, 2015 (the &#8220;Subsidiary&#8221;). Pursuant to the License Agreement, Ocure granted to the Subsidiary an exclusive, sub-licensable, worldwide, license (the &#8220;License&#8221;) to Ocure&#8217;s semi-occlusive wound dressing for ambulatory treatment of acute and chronic anal fissure, pursuant to Ocure&#8217;s patents and patent applications (the &#8220;Licensed Technology&#8221;) and to its production, use, import, offer for sale, sell, lease, distribute, or otherwise commercialize the Licensed Technology for uses classified as medical devices, or those otherwise approved ultimately as an OTC (over-the-counter) remedy. In a further step to exit this line of business due to Madison-IL not achieving the projected development milestones, the Company elected January 4, 2017 to terminate the Ocure License and write off the remaining investment. On April 1, 2017, by consent action of a majority of the Company&#8217;s shareholders, Madison Ventures sold Madison-IL, the wholly owned subsidiary, to a shareholder of the Company.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Under the License Agreement, the Company was obligated as consideration for the Licensed Technology to provide the Subsidiary $250,000 for the commercialization of the Licensed Technology, payable according to the following schedule:</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; font-size-adjust: none; font-stretch: normal"> <tr> <td style="width: 4%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: top; width: 4%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#183;</font></td> <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$10,000 upon execution of the Letter of Intent (paid February 27, 2015 to Ocure),</font></td></tr> <tr> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#183;</font></td> <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$90,000 at the later of May 11, 2015 or the final signing date of the License Agreement (the &#8220;Effective Date&#8221;),</font></td></tr> <tr> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#183;</font></td> <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$50,000 on or before March 4, 2016, and</font></td></tr> <tr> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#183;</font></td> <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$100,000 on or before April 8, 2016 (collectively, the &#8220;First $250,000 Tranche&#8221;).</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The Effective Date occurred upon satisfaction of the Condition Precedent, as defined in the License Agreement, and approval of the Agreement by the Chief Scientist of the Israeli Ministry of the Economy. The License Agreement Effective Date is November 11, 2015; the date approval of the Chief Scientist of the Israeli Ministry of the Economy was received. Upon the 6-month anniversary of the Effective Date, if the Company had paid the First $250,000 Tranche, then Ocure would have transferred certain assets, as defined, to the Subsidiary, and the Company would be obligated to provide the Subsidiary a second $250,000 tranche, payable as follows:</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; font-size-adjust: none; font-stretch: normal"> <tr> <td style="width: 4%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: top; width: 4%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#183;</font></td> <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$100,000 on or before August 12, 2016,</font></td></tr> <tr> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#183;</font></td> <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$100,000 on or before September 23, 2016, and</font></td></tr> <tr> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#183;</font></td> <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$50,000 on or before October 28, 2016.</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The License Agreement terminated, on a country-by-country basis, the later of: (a) the date of expiration of the last to expire of Ocure&#8217;s rights in Ocure Patents in such country or such other grant of statutory exclusivity, or (b) the end of a period of fifteen (15) years from the date of making the first commercial sale, as defined, in such country; unless sooner terminated pursuant to the terms of the License Agreement.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Immediately after the Effective Date of the License Agreement and for the period ending March 31, 2016 (as amended), the shareholders of Ocure and certain individuals designated by Ocure had the opportunity to purchase up to an aggregate of 7,100,000 (1,775,000 presplit) shares of the Company&#8217;s Common Stock at the par value of $0.001 per share. In addition, the Company was to establish an incentive stock option plan reserving up to 20% of the Company&#8217;s issued share capital, as of the closing. The right to purchase an aggregate of 7,100,000 (1,775,000 presplit) shares of the Company&#8217;s Common Stock expired unexercised and the Company has not established an incentive stock option plan.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In consideration of the license for the Licensed Technology and with respect to any inventions, improvement, development or enhancement based upon, consists of, comprises, contains or incorporates the Licensed Technology invented following the Effective Date by the Subsidiary, its affiliate or sub-licensee (the &#8220;New Inventions&#8221;), the Subsidiary agreed to pay Ocure royalties calculated as 5% of gross sales. In addition, the Subsidiary agreed to pay Ocure 20% of any cash or non-cash consideration received, whether for sublicense initiation fee, annual fee, sublicense milestone payments, or other such non-sale based royalty consideration payable by a sublicense as consideration for or under a sublicense.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The Company was in default of the First $250,000 Tranche aggregate payment due on April 8, 2016. Upon the six month anniversary of the Effective Date (May 11, 2016) no assets were transferred by Ocure to the Company&#8217;s subsidiary. As of March 31, 2017, the Company had advanced funds aggregating $221,850 to the Subsidiary and paid Ocure $10,000 under the License Agreement. As such, the Company was in breach of its obligations under the License Agreement, but had not received notice of termination from Ocure. Madison-IL had not achieved the projected development milestones and the Company elected January 4, 2017 to terminate the Ocure License.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">As of March 31, 2017, the Subsidiary in furtherance of the commercialization of the Licensed Technology has incurred an aggregate of $266,722 of costs recorded as the investment in technology license. At March 31, 2017, the additional costs recorded as the investment in technology license represent vendor obligations payable. In a further step to exit this line of business due to Madison-IL not achieving the projected development milestones, the Company elected January 4, 2017 to terminate the Ocure License and write off the remaining investment. On April 1, 2017, by consent action of a majority of the Company&#8217;s shareholders, Madison Ventures sold Madison-IL, the wholly owned subsidiary, to a shareholder of the Company.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Accordingly, the investment in the technology license of $266,722, at January 4, 2017, has been written off and recognized as an expense during the year ended March 31, 2017. As of December 31 and March 31, 2017, zero technology license costs are capitalized.</font></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Due to related parties at December 31 and March 31, 2017 consisted of the following:</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; font-size-adjust: none; font-stretch: normal"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" id="hdcell" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>December 31,</b></font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>March 31,</b></font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2017</b></font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2017</b></font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" id="ffcell" style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Balance at beginning of period</font></td> <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">236,942</font></td> <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">213,442</font></td> <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: top; padding-left: 11.25pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Funds advanced</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">15,000</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">23,500</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding-left: 11.25pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Funds repaid</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(100</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">)&#160;</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Balance at end of period</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">251,842</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">236,942</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On July 3, July 8, July 10, August 12, November 12, November 13, 2014, January 23, February 27, March 5, May 16, June 17, June 30, July 6, August 13, November 17, 2015, February 13, February 20, March 7 and March 17, 2016, Ecogenics Limited, a shareholder of the Company, advanced the Company $2,000, $775, $1,460, $2,000, $2,000, $1,763, $2,000, $10,000, $3,525, $4,093, $2,755, $1,083, $5,000, $3,000, $2,041, $961, $5,000, $3,300, and $50,000 respectively, as a series of unsecured obligations.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On August 11 and November 10, 2016, Pompeii Finance, a shareholder of the Company, advanced the Company $6,500 and $5,250, respectively, as a series of unsecured obligations.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On April 1, 2017, by consent action of a majority of the Company&#8217;s shareholders, Madison Ventures negotiated the sale of Madison-IL, following the termination of the Ocure License, to Pompeii Finance for $100 which was deducted from the funds owed to Pompeii for the above advances. See Note 7.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The net funds aggregating $114,406 were used to pay operating costs of the Company. The aggregate obligations bear no interest, have no fixed term and are not evidenced by any written agreements. The shareholders are under no obligation to advance additional funds to the Company.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On December 3, December 24, 2015, January 4, January 6, January 15, November 10, 2016, February 7, March 30, and September 5, 2017, Morpheus Financial Corporation Limited, a shareholder of the Company, advanced the Company $37,473, $7,500, $7,326, $8,412, $49,975, $3,750, $5,000, $3,000, and $15,000, respectively, as a series of unsecured obligations. The funds aggregating $137,436 were used to pay operating costs of the Company. On February 7, and June 19, 2018, Morpheus advanced the Company $20,538 and $1,167, respectively, to pay operating costs of the Company.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On January 8, 2016, the aggregate advances received and future advances from Morpheus were structured as a noninterest bearing unsecured non-recourse loan due January 31, 2017. The shareholder, if requested by the Company, agreed to advance additional funds to the Company up to a maximum of $250,000 subject to certain timing limitation as defined. The Company is currently is negotiating an extension of the due date.</font></p> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Long term debt at December 31 and March 31, 2017 consisted of the following:</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; font-size-adjust: none; font-stretch: normal"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" id="hdcell" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>December 31,</b></font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>March 31,</b></font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2017</b></font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2017</b></font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" id="ffcell" style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Balance at beginning of period</font></td> <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">110,000</font></td> <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: top; padding-left: 11.25pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Funds advanced</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">65</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">110,000</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding-left: 11.25pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Funds repaid</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Balance at end of period</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">110,065</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">110,000</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On April 18, 2016, the Company entered into a five year non-interest bearing loan agreement for $110,000 with Cronus Overseas Corporation, a shareholder of the Company. Proceeds were used to fund the Technology acquisition and operations. If the loan is not repaid on or before April 15, 2021 the loan amount will be subject to default interest on the amount then outstanding of ten percent (10%) per month during the first 30 days of delinquency, fifteen percent (15%) per month during the 31 to 60 days of delinquency, twenty percent (20%) per month during the 61 to 90 days of delinquency (the &#8220;Default Interest&#8221;). If the loan amount remains unpaid after 90 days the lender, at its option, will be entitled to a default payment of one hundred fifty-nine percent (159%) of the then outstanding loan amount inclusive of the Default Interest. On September 25, 2017, Cronus paid on behalf of the Company $65 for operating costs of the Company.</font></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">These financial statements have been prepared on a going concern basis which assumes the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future. The Company has incurred losses since inception resulting in an accumulated deficit of approximately $491,000 as of December 31, 2017 and further losses are anticipated in the development of its business raising substantial doubt about the Company&#8217;s ability to continue as a going concern. The ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. The Company&#8217;s operating expenditure plan for the next fiscal year ending March 31, 2018 will require cash. Management intends to finance operating costs over the next twelve months with the issuance of common shares and/or related party borrowings.</font></p> <p style="margin: 0pt"></p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" id="hdcell" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>December 31,</b></font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>March 31,</b></font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2017</b></font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2017</b></font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" id="ffcell" style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Balance at beginning of period</font></td> <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">236,942</font></td> <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">213,442</font></td> <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: top; padding-left: 11.25pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Funds advanced</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">15,000</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">23,500</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding-left: 11.25pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Funds repaid</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(100</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">)&#160;</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Balance at end of period</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">251,842</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">236,942</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" id="hdcell" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>December 31,</b></font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>March 31,</b></font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2017</b></font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2017</b></font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" id="ffcell" style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Balance at beginning of period</font></td> <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">110,000</font></td> <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: top; padding-left: 11.25pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Funds advanced</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">65</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">110,000</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding-left: 11.25pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Funds repaid</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Balance at end of period</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">110,065</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">110,000</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> </table> <p style="margin: 0pt"></p> 110000 110065 1000 24000 25000 24435 -31052 -319427 -10291 25000 8639 11172 66795 -8639 -55623 3725 15065 125500 65 110000 15000 15500 -187454 187454 -23704 2606 -6192 5900 6964 50629 4792 2100 -48911 1387 <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The accompanying unaudited condensed consolidated financial statements are presented in United States dollars and are prepared using the accrual method of accounting which conforms to generally accepted accounting principles in the United States of America (&#8220;US GAAP&#8221;) for interim financial reporting and the instructions for Form 10-Q pursuant to the rules and regulations of the Securities and Exchange Commission. Accordingly, they do not include all information and footnote disclosures necessary for a complete presentation of the financial position, results of operations, cash flows, and stockholders equity in conformity with generally accepted accounting principles. In the opinion of management, all adjustments considered necessary for a fair presentation of the results of operations and financial position have been included and all such adjustments are of a normal recurring nature.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The unaudited condensed consolidated balance sheet of the Company as of December 31, 2017, and the related consolidated balance sheet of the Company as of March 31, 2017, which is derived from the Company's audited financial statements, the unaudited condensed consolidated statement of operations and cash flows for the Nine Months ended December 31, 2017 and 2016 and the condensed consolidated statement of stockholders equity for the period of March 31, 2016 to December 31, 2017 and are included in this document. These unaudited condensed consolidated financial statements should be read in conjunction with the March 31, 2017 audited financial statements and related notes included in the Company&#8217;s most recent Form 10-K as filed with the Securities and Exchange Commission on March 20, 2018.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Operating results for the Nine Months ended December 31, 2017 are not necessarily indicative of the results that can be expected for the year ending March 31, 2018.</font></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><u>Employment Agreements</u></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On April 2, 2014, Mr. Gene Gregorio was appointed the Company&#8217;s President, Chief Executive Officer, Chief Financial Officer and sole Director. On April 20, 2014, the Company agreed to issue Mr. Gregorio 1,000,000 (250,000 presplit) restricted shares of the Company&#8217;s Common Stock, valued at $25,000, based on the market close, as compensation for his services for an initial term of one year (the &#8220;April 20<sup>th</sup> Agreement&#8221;). On March 31, 2015, the Company issued Mr. Gregorio the agreed 1,000,000 restricted shares of the Company&#8217;s Common Stock.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In addition, if during the term of the April 20<sup>th</sup> Agreement Mr. Gregorio&#8217;s direct efforts result in a consummated financing for the Company he shall be paid a 5.0% fee on such financing received by the Company, at his option, as either cash or shares of Company&#8217;s Common Stock at the offering price. Additionally, the Company will grant Mr. Gregorio a 2 year stock option priced at the current market trading price equal to 5% of the aggregate shares issued to investors within the financing</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On April 14, 2015, the April 20<sup>th</sup> Agreement with Mr. Gene Gregorio was extended for a second year under the same terms and conditions. Mr. Gregorio will be issued 1,000,000 restricted shares of the Company&#8217;s Common Stock, valued at $25,000, based on the market close, as compensation for his services for the second year the extended April 20<sup>th</sup> Agreement.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On August 9, 2016, the Company issued Mr. Gregorio the agreed 1,000,000 restricted shares of the Company&#8217;s Common Stock for services rendered during the period April 21, 2015 to April 20, 2016.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On April 23, 2018, Mr. Gregorio resigned as the Company&#8217;s President, Chief Executive Officer, Chief Financial Officer and as the sole Director.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><u>Madison-IL</u></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On March 31, 2017, the Company forgave the intercompany debt between Madison Ventures, Inc. and Madison-IL Ltd which aggregated $231,850. The Company, established Madison-IL on July 9, 2015 as a wholly-owned subsidiary, incorporated under the laws of the country of Israel to address the Company&#8217;s requirement for an Israeli company to operate and hold the assets associated with Ocure License. Following the Company&#8217;s January 4, 2017 decision to terminate the Ocure License and to dissolve or liquidate Madison-IL, by consent action of a majority of the Company&#8217;s shareholders, Madison Ventures negotiated the sale of Madison-IL to Pompeii Finance, a shareholder of the Company, on April 1, 2017 for $100 which was deducted from the funds owed to Pompeii for related party advances. See Note 5. Pompeii assumes the remaining assets and liabilities of Madison-IL which on March 31, 2017 aggregated 23,844 NIL and 250,996 NIL or approximately $6,566 and $69,115, respectively. On April 1, 2017, the Company recognized a net gain from the sale of Madison-IL of $48,911 ($62,549 of net liabilities eliminated, offset by $13,738 of other comprehensive losses from prior period foreign translation adjustments and $100 of proceeds received).</font></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The Company&#8217;s capitalization is 300,000,000 shares of common stock, with a par value of $0.001 per share, with 29,400,000 shares issued and outstanding at December 31, 2017 and March 31, 2017. On April 11, 2016, the Company effected a four for one forward stock split of our i) authorized and ii) issued and outstanding shares of common stock. All share information has been restated for all periods presented giving retroactive effect of the April 11, 2016 four to one forward stock split. Prior to the forward stock split the Company had 75,000,000 authorized shares of common stock, with a par value of $0.001 per share and 7,100,000 shares issued and outstanding at March 31, 2016.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">As of March 31, 2017 and 2016, the Company has not granted any stock options or stock warrants.</font></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods presented. The Company is required to make judgments and estimates about the effect of matters that are inherently uncertain. The Company regularly evaluates estimates and assumptions related to the useful life and recoverability of long-lived assets, deferred income tax asset valuations and loss contingences. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. Although, webelieve our judgments and estimates are appropriate, actual future results may be different; if different assumptions or conditions were to prevail, the results could be materially different from our reported results.</font></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Codification topic 718 &#8220;Stock Compensation&#8221; requires that the cost resulting from all share-based transactions be recorded in the financial statements and establishes fair value as the measurement objective for share-based payment transactions with employees and acquired goods or services from non-employees. The codification also provides guidance on valuing and expensing these awards, as well as disclosure requirements of these equity arrangements. The Company adopted the codification upon creation of the company and will expense share based costs in the period incurred. The Company has not adopted a stock option plan or completed a share-based transaction; accordingly no stock-based compensation has been recorded to date.</font></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The Company&#8217;s management has evaluated all the recently issued, but not yet effective, accounting standards that have been issued or proposed by the FASB or other standards-setting bodies through the filing date of these financial statements and does not believe the future adoption of any such pronouncements will have a material effect on the Company&#8217;s financial position and results of operations.</font></p> 23661 8507 41809 10276 1387 48911 244904 12321 257225 266722 815 4561 11953 15 -24435 25390 314925 10291 65 -5649 -4489 -5662 -4502 0.00 -0.00 -0.01 -0.00 29400000 29400000 28923636 29400000 -3377 -3155 100 1000000 1000000 1000000 250000 25000 25000 6566 69115 48911 100 231850 four for one 200000000 8639 -515531 -491096 78100 78100 29400 29400 110000 110065 320408 273531 6192 77274 21689 8639 13738 13738 13 13 <p style="font: 10pt/normal Segoe UI,sans-serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In addition, if during the term of the April 20th Agreement Mr. Gregorio&#8217;s direct efforts result in a consummated financing for the Company he shall be paid a 5.0% fee on such financing received by the Company, at his option, as either cash or shares of Company&#8217;s Common Stock at the offering price. Additionally, the Company will grant Mr. Gregorio a 2 year stock option priced at the current market trading price equal to 5% of the aggregate shares issued to investors within the financing</font></p> State of Nevada 2009-09-14 221850 250000 250000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Licensed Technology, payable according to the following schedule:</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; font-size-adjust: none; font-stretch: normal"> <tr> <td style="width: 4%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: top; width: 4%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#183;</font></td> <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$10,000 upon execution of the Letter of Intent (paid February 27, 2015 to Ocure),</font></td></tr> <tr> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#183;</font></td> <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$90,000 at the later of May 11, 2015 or the final signing date of the License Agreement (the &#147;Effective Date&#148;),</font></td></tr> <tr> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#183;</font></td> <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$50,000 on or before March 4, 2016, and</font></td></tr> <tr> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#183;</font></td> <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$100,000 on or before April 8, 2016 (collectively, the &#147;First $250,000 Tranche&#148;).</font></td></tr> </table> <p style="margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Second $250,000 tranche, payable as follows:</font></p> <p style="margin: 0; text-align: justify"></p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr> <td style="width: 4%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: top; width: 4%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#183;</font></td> <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$100,000 on or before August 12, 2016,</font></td></tr> <tr> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#183;</font></td> <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$100,000 on or before September 23, 2016, and</font></td></tr> <tr> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#183;</font></td> <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$50,000 on or before October 28, 2016.</font></td></tr> </table> <p style="margin: 0; text-align: justify"></p> 10000 250000 266722 7100000 1775000 0.20 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The right to purchase an aggregate of 7,100,000 (1,775,000 presplit) shares of the Company&#8217;s Common Stock expired unexercised and the Company has not established an incentive stock option plan.</font></p> 0.05 0.20 15000 23500 -100 The shareholder, if requested by the Company, agreed to advance additional funds to the Company up to a maximum of $250,000 subject to certain timing limitation as defined. 65 110000 110000 <p style="margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">If the loan is not repaid on or before April 15, 2021 the loan amount will be subject to default interest on the amount then outstanding of ten percent (10%) per month during the first 30 days of delinquency, fifteen percent (15%) per month during the 31 to 60 days of delinquency, twenty percent (20%) per month during the 61 to 90 days of delinquency (the &#147;Default Interest&#148;). If the loan amount remains unpaid after 90 days the lender, at its option, will be entitled to a default payment of one hundred fifty-nine percent (159%) of the then outstanding loan amount inclusive of the Default Interest.</font></p> -1 -2551 0.538 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On February 7, 2018, Morpheus Financial Corporation Limited, a shareholder of the Company, advanced the Company $20,538 (advanced as 25,735 CND) to pay operating costs.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On April 23, 2018, the Company entered into a Plan of Reorganization and Agreement of Securities Exchange (the &#8220;Agreement&#8221;) with Firetainment Inc. (&#8220;Firetainment&#8221;), a Florida Corporation. The Agreement will result in the merger of Firetainment into Madison Ventures with the corporation to survive as Firetainment Inc. Pursuant to the Agreement the Company agreed to issue Firetainment two hundred million (200,000,000) common shares in exchange for all of the shares of Firetainment. This issuance will result in a change in control of the Company. Under the Agreement, upon execution, Firetainment received the immediate right to the appointment of the directors and officers of the surviving corporation by the resignation of the existing sole director and officer of the Company and the simultaneous appointment of its own designee being the newly appointed sole director and officer. The closing of the Agreement will take place upon the delivery and completion of Firetainment audited statements for the period ending March 31, 2018, unless another time or date, or both, are agreed to in writing by the parties.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Also on April 23, 2018, the Board of Directors appointed William Shawn Clark as our Chief Executive Officer, Chief Financial Officer, Secretary and Treasurer as well as our Sole Director. Concurrent with Mr. Clarks&#8217; appointment, Eugenio Gregorio resigned as Chief Executive Officer, Chief Financial Officer, Secretary and Treasurer as well as our Sole Director. Mr. Clark, the sole owner of Firetainment, is now our sole officer and director.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On June 19, 2018, Morpheus Financial Corporation Limited, a shareholder of the Company, advanced the Company $1,167 to pay operating costs.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On June 29, 2018, Firetainment Inc. advanced the Company $10,000 to pay operating costs.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On July 5, 2018, holders of 15,820,000 shares of the Company&#8217;s outstanding common stock, representing approximately 53.8% of the outstanding shares, approved, by written consents, an amendment to the articles of incorporation of the Company to change the name of the Company from &#8220;Madison Ventures Inc.&#8221; to &#8220;Viabuilt Ventures Inc.&#8221; On July 5, 2018, there were no written consents received by the Company representing a vote against, abstention or broker non-vote with respect to the proposal to change the name. The Company expects to change its name when all regulatory approvals have been obtained.</font></p> EX-101.SCH 6 mdsv-20171231.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit) (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Condensed financial statements link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Nature of operations link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Going concern link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Investment in technology license link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Due to related parties link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Long-term debt due to related party link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Related party transactions link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Capital stock link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Nature of operations (Policies) link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Due to related parties (Tables) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Long-term debt due to related party (Tables) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Nature of operations (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Going concern (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Investment in technology license (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Due to related parties (Details) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Due to related parties (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Long-term debt due to related party (Details) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Long-term debt due to related party (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Related party transactions (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Capital stock (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Subsequent Event (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 mdsv-20171231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 8 mdsv-20171231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 9 mdsv-20171231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Equity Components [Axis] Common Stock Additional Paid-In Capital Accumulated other comprehensive Income (loss) Accumulated Deficit Forward stock split [Member] Related Party Transaction [Axis] Mr. Gregorio [Member] Mr. Gene Gregorio [Member] Long-term Debt, Type [Axis] Cronus Overseas Corporation [Member] Ecogenics Limited [Member] Pompeii Finance [Member] Morpheus Financial Corporation Limited [Member] Research and Development Arrangement, Contract to Perform for Others, Type [Axis] License Agreement [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Business Acquisition [Axis] Madison-IL Ltd [Member] Plan Name [Axis] Securities Exchange Agreement [Member] Legal Entity [Axis] Firetainment Inc [Member] Madison Ventures, Inc [Member] Report Date [Axis] April 1, 2017 [Member] License Agreement One [Member] Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Is Entity a Well-known Seasoned Issuer? Is Entity a Voluntary Filer? Is Entity's Reporting Status Current? Entity Filer Category Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Condensed Consolidated Balance Sheets ASSETS Current assets: Cash Total assets LIABILITIES AND SHAREHOLDERS' EQUITY (DEFICIT) Current liabilities: Accounts payable Accrued liabilities Due to related parties Total current liabilities Long-term liabilities: Long-term debt due to related party Total long-term liabilities Total Liabilities Commitments and Contingencies Shareholders' equity (deficit): Common stock: 300,000,000 shares authorized of $0.001 par value; 29,400,000 and 29,400,000 shares issued and outstanding as of December 31 and March 31, 2017, respectively Additional paid-in capital Accumulated deficit Accumulated other comprehensive income (loss) Total shareholders' equity (deficit) Total liabilities and shareholders' equity (deficit) Condensed Consolidated Balance Sheets Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Condensed Consolidated Statements Of Operations Operating costs: Consulting and professional fees Stock based compensation Insurance Gain on disposition of foreign subsidiary, net of $13,738 foreign translation (loss) from prior periods Impairment of technology license Other general & administrative expenses Total operating costs Other income (expense): Foreign exchange gain (loss) Interest expense Total other income (expense) Net income (loss) Income (loss) per common share: Basic and diluted Weighted average common shares outstanding: Basic and diluted Comprehensive income (loss): Net income (loss) Other comprehensive income Foreign currency translation Comprehensive income (loss) Statement [Table] Statement [Line Items] Beginning Balance, Shares Beginning Balance, Amount Stock issuance for service, Shares Stock issuance for service, Amount Comprehensive income (loss) Disposition of foreign subsidiary Ending Balance, Shares Ending Balance, Amount Condensed Consolidated Statements Of Cash Flows Cash flows from operating activities: Adjustments to reconcile net loss to net cash (used in) provided by operating activities: Employee stock based compensation (Gain) on disposition of foreign subsidiary Changes in operating assets and liabilities: Decrease in prepaid expenses Decrease in miscellaneous receivable Increase in accounts payable Increase in accrued liabilities Net cash (used in) provided by operating activities Cash flows from investing activities: Acquisition of technology license Net cash (used in) investing activities Cash flows from financing activities: Proceeds from related parties Proceeds from non-interest bearing term-debt Net cash provided by financing activities Effect of exchange rate changes on cash Net (decrease) in cash Cash, beginning of the year Cash, end of the quarter Non-cash investing and financing activities Shares issued for accrued compensation Supplement cash flow disclosure: Interest paid Income tax paid Notes to Financial Statements 1. Condensed financial statements 2. Nature of operations 3. Going concern 4. Investment in technology license 5. Due to related parties 6. Long-term debt due to related party 7. Related party transactions 8. Capital stock 9. Subsequent Events Nature Of Operations Use of Estimates and Assumptions Share-based Compensation Recent Accounting Pronouncements Due To Related Parties Due to related parties Long-term Debt Due To Related Party Long term debt Nature Of Operations State of incorporation Date of incorporation Going Concern Advance for commercialization of the licensed technology Advance for commercialization of the licensed technology description Fees paid for commercialization licensed technology Default of the first tranche aggregate payment Investment in technology license Purchase of common stock, shares Purchase of common stock, presplit shares Incentive stock option, percentage Right to purchase of common stock shares, description Occur royalties payable, percentage Occur cash payable, percentage Due To Related Parties Balance at beginning of period Funds advanced Funds repaid Balance at end of period Advance of additional funds, description Due to related party Adjustment of negotiated sale amount Long-term Debt Due To Related Party Balance at beginning of period Funds advanced Funds repaid Balance at end of period Long-term debt Default interest description Operating costs Common stock restricted shares Common stock restricted shares presplit Value of restricted shares Stock option investing period description Shares issued for service Business acquisition remaining assets Business acquisition remaining liabilities Net liabilities Business combination net gain from sale Foreign translation adjustments Forgiveness of debt Forward stock split Common shares exchange upon execution under agreement Common stock, shares outstanding holding percentage Funds advanced. Repayments. Assets Liabilities, Current Liabilities, Noncurrent Stockholders' Equity Attributable to Parent Liabilities and Equity Insurance Recoveries Goodwill, Foreign Currency Translation Gain (Loss) Interest Expense Nonoperating Income (Expense) Weighted Average Number of Shares Outstanding, Basic and Diluted Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax Shares, Issued Net Cash Provided by (Used in) Operating Activities Payments to Acquire Software Net Cash Provided by (Used in) Investing Activities Net Cash Provided by (Used in) Financing Activities Schedule of Related Party Transactions [Table Text Block] FundsAdvancedLongTermDebtNoncurrent FundsRepaidLongTermDebtNoncurrent EX-101.PRE 10 mdsv-20171231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.10.0.1
Document and Entity Information - shares
9 Months Ended
Dec. 31, 2017
Jul. 20, 2018
Document And Entity Information    
Entity Registrant Name Madison Ventures Inc.  
Entity Central Index Key 0001575975  
Document Type 10-Q  
Document Period End Date Dec. 31, 2017  
Amendment Flag false  
Current Fiscal Year End Date --03-31  
Is Entity a Well-known Seasoned Issuer? No  
Is Entity a Voluntary Filer? No  
Is Entity's Reporting Status Current? No  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   29,400,000
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2018  
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Balance Sheets - USD ($)
Dec. 31, 2017
Mar. 31, 2017
Current assets:    
Cash $ 8,639
Total assets 8,639
Current liabilities:    
Accounts payable 21,689 77,274
Accrued liabilities 6,192
Due to related parties 251,842 236,942
Total current liabilities 273,531 320,408
Long-term liabilities:    
Long-term debt due to related party 110,065 110,000
Total long-term liabilities 110,065 110,000
Total Liabilities 383,596 430,408
Commitments and Contingencies
Shareholders' equity (deficit):    
Common stock: 300,000,000 shares authorized of $0.001 par value; 29,400,000 and 29,400,000 shares issued and outstanding as of December 31 and March 31, 2017, respectively 29,400 29,400
Additional paid-in capital 78,100 78,100
Accumulated deficit (491,096) (515,531)
Accumulated other comprehensive income (loss) (13,738)
Total shareholders' equity (deficit) (383,596) (421,769)
Total liabilities and shareholders' equity (deficit) $ 8,639
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares
Dec. 31, 2017
Mar. 31, 2017
Shareholders' equity (deficit):    
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 300,000,000 300,000,000
Common stock, shares issued 29,400,000 29,400,000
Common stock, shares outstanding 29,400,000 29,400,000
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2017
Dec. 31, 2016
Operating costs:        
Consulting and professional fees $ 10,276 $ 8,507 $ 23,661 $ 41,809
Stock based compensation 1,387
Insurance 1 2,551
Gain on disposition of foreign subsidiary, net of $13,738 foreign translation (loss) from prior periods (48,911)
Impairment of technology license 12,321 257,225
Other general & administrative expenses 15 4,561 815 11,953
Total operating costs 10,291 25,390 (24,435) 314,925
Other income (expense):        
Foreign exchange gain (loss) (5,649) (4,489)
Interest expense (13) (13)
Total other income (expense) (5,662) (4,502)
Net income (loss) $ (10,291) $ (31,052) $ 24,435 $ (319,427)
Income (loss) per common share:        
Basic and diluted $ (0.00) $ (0.00) $ 0.00 $ (0.01)
Weighted average common shares outstanding:        
Basic and diluted 29,400,000 29,400,000 29,400,000 28,923,636
Comprehensive income (loss):        
Net income (loss) $ (10,291) $ (31,052) $ 24,435 $ (319,427)
Other comprehensive income        
Foreign currency translation 3,377 3,155
Comprehensive income (loss) $ (10,291) $ (27,675) $ 24,435 $ (316,272)
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit) (Unaudited) - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated other comprehensive Income (loss)
Total
Beginning Balance, Shares at Mar. 31, 2016 28,400,000        
Beginning Balance, Amount at Mar. 31, 2016 $ 28,400 $ 54,100 $ (194,669) $ (76) $ (112,245)
Stock issuance for service, Shares 1,000,000        
Stock issuance for service, Amount $ 1,000 24,000 25,000
Comprehensive income (loss) (320,862) (13,662) (334,524)
Ending Balance, Shares at Mar. 31, 2017 29,400,000        
Ending Balance, Amount at Mar. 31, 2017 $ 29,400 78,100 (515,531) (13,738) (421,769)
Comprehensive income (loss) 24,435 24,435
Disposition of foreign subsidiary 13,738 13,738
Ending Balance, Shares at Dec. 31, 2017 29,400,000        
Ending Balance, Amount at Dec. 31, 2017 $ 29,400 $ 78,100 $ (491,096) $ (383,596)
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Cash flows from operating activities:    
Net income (loss) $ 24,435 $ (319,427)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:    
Employee stock based compensation 1,387
Impairment of technology license 257,225
(Gain) on disposition of foreign subsidiary (48,911)
Changes in operating assets and liabilities:    
Decrease in prepaid expenses 2,100
Decrease in miscellaneous receivable 4,792
Increase in accounts payable 6,964 50,629
Increase in accrued liabilities (6,192) 5,900
Net cash (used in) provided by operating activities (23,704) 2,606
Cash flows from investing activities:    
Acquisition of technology license (187,454)
Net cash (used in) investing activities (187,454)
Cash flows from financing activities:    
Proceeds from related parties 15,000 15,500
Proceeds from non-interest bearing term-debt 65 110,000
Net cash provided by financing activities 15,065 125,500
Effect of exchange rate changes on cash 3,725
Net (decrease) in cash (8,639) (55,623)
Cash, beginning of the year 8,639 66,795
Cash, end of the quarter 11,172
Non-cash investing and financing activities    
Shares issued for accrued compensation 25,000
Supplement cash flow disclosure:    
Interest paid
Income tax paid
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed financial statements
9 Months Ended
Dec. 31, 2017
Notes to Financial Statements  
1. Condensed financial statements

The accompanying unaudited condensed consolidated financial statements are presented in United States dollars and are prepared using the accrual method of accounting which conforms to generally accepted accounting principles in the United States of America (“US GAAP”) for interim financial reporting and the instructions for Form 10-Q pursuant to the rules and regulations of the Securities and Exchange Commission. Accordingly, they do not include all information and footnote disclosures necessary for a complete presentation of the financial position, results of operations, cash flows, and stockholders equity in conformity with generally accepted accounting principles. In the opinion of management, all adjustments considered necessary for a fair presentation of the results of operations and financial position have been included and all such adjustments are of a normal recurring nature.

 

The unaudited condensed consolidated balance sheet of the Company as of December 31, 2017, and the related consolidated balance sheet of the Company as of March 31, 2017, which is derived from the Company's audited financial statements, the unaudited condensed consolidated statement of operations and cash flows for the Nine Months ended December 31, 2017 and 2016 and the condensed consolidated statement of stockholders equity for the period of March 31, 2016 to December 31, 2017 and are included in this document. These unaudited condensed consolidated financial statements should be read in conjunction with the March 31, 2017 audited financial statements and related notes included in the Company’s most recent Form 10-K as filed with the Securities and Exchange Commission on March 20, 2018.

 

Operating results for the Nine Months ended December 31, 2017 are not necessarily indicative of the results that can be expected for the year ending March 31, 2018.

XML 18 R8.htm IDEA: XBRL DOCUMENT v3.10.0.1
Nature of operations
9 Months Ended
Dec. 31, 2017
Notes to Financial Statements  
2. Nature of operations

Madison Ventures Inc. (“Company”) was incorporated in the State of Nevada as a for-profit company on September 14, 2009 and established a fiscal year end of March 31. The Company initially was engaged in the acquisition, exploration and development of natural resource properties. On February 27, 2015, the Company terminated the acquisition of the mineral claim and entered into a letter of intent with Ocure Ltd. (“Ocure”), pursuant to which the Company agreed to exclusively license certain technology from Ocure related to the development of products and devices for the treatment of anal fissures and on August 5, 2015, entered into an exclusive license agreement to Ocure’s semi-occlusive wound dressing for ambulatory treatment of acute and chronic anal fissures (the “Ocure License”). On July 9, 2015, the Company established the wholly-owned subsidiary Madison-IL Ltd., incorporated under the laws of the country of Israel to address the Company’s requirement for an Israeli company to operate and hold the assets associated with Ocure License. However, the Company has not made all payments required under the Ocure License and is in breach of that agreement. Ocure has not provided formal notice of termination. The License Agreement has not been extended or amended, and there was a substantial risk the agreement would be cancelled. Accordingly the investment in the technology license of $244,904, at September 30, 2016, is impaired and written off as a result of these circumstances. In a further step to exit this line of business due to Madison-IL not achieving the projected development milestones, the Company elected January 4, 2017 to terminate the Ocure License and write off the remaining investment. On April 1, 2017, by consent action of a majority of the Company’s shareholders, Madison Ventures sold Madison-IL, the wholly owned subsidiary, to a shareholder of the Company. See Note 4. The Company has no revenues, a limited operating history, and no current line of business.

 

The success of the Company is dependent upon the identification of products or services, the ability of the Company to obtain the necessary financing to develop such products or services, and upon future profitable operations.

 

Use of Estimates and Assumptions

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods presented. The Company is required to make judgments and estimates about the effect of matters that are inherently uncertain. The Company regularly evaluates estimates and assumptions related to the useful life and recoverability of long-lived assets, deferred income tax asset valuations and loss contingences. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. Although, webelieve our judgments and estimates are appropriate, actual future results may be different; if different assumptions or conditions were to prevail, the results could be materially different from our reported results.

 

Share-based Compensation

 

Codification topic 718 “Stock Compensation” requires that the cost resulting from all share-based transactions be recorded in the financial statements and establishes fair value as the measurement objective for share-based payment transactions with employees and acquired goods or services from non-employees. The codification also provides guidance on valuing and expensing these awards, as well as disclosure requirements of these equity arrangements. The Company adopted the codification upon creation of the company and will expense share based costs in the period incurred. The Company has not adopted a stock option plan or completed a share-based transaction; accordingly no stock-based compensation has been recorded to date.

 

Recent Accounting Pronouncements

 

The Company’s management has evaluated all the recently issued, but not yet effective, accounting standards that have been issued or proposed by the FASB or other standards-setting bodies through the filing date of these financial statements and does not believe the future adoption of any such pronouncements will have a material effect on the Company’s financial position and results of operations.

XML 19 R9.htm IDEA: XBRL DOCUMENT v3.10.0.1
Going concern
9 Months Ended
Dec. 31, 2017
Notes to Financial Statements  
3. Going concern

These financial statements have been prepared on a going concern basis which assumes the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future. The Company has incurred losses since inception resulting in an accumulated deficit of approximately $491,000 as of December 31, 2017 and further losses are anticipated in the development of its business raising substantial doubt about the Company’s ability to continue as a going concern. The ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. The Company’s operating expenditure plan for the next fiscal year ending March 31, 2018 will require cash. Management intends to finance operating costs over the next twelve months with the issuance of common shares and/or related party borrowings.

XML 20 R10.htm IDEA: XBRL DOCUMENT v3.10.0.1
Investment in technology license
9 Months Ended
Dec. 31, 2017
Notes to Financial Statements  
4. Investment in technology license

On February 27, 2015, we entered into a letter of intent (the “Letter of Intent”) with Ocure Ltd. (“Ocure”), an Israeli corporation, pursuant to which the Company would be obligated to exclusively license certain technology from Ocure under terms of a license agreement to be negotiated between the Company and Ocure. The Letter of Intent terminated when the Company did not make the second required payment, however the Company continued to negotiate with Ocure. On August 5, 2015, as amended February 26, 2016, the company entered into an exclusive license agreement (the “License Agreement”) with Ocure and Madison-IL Ltd., a wholly-owned subsidiary of the Company incorporated in Israel on July 9, 2015 (the “Subsidiary”). Pursuant to the License Agreement, Ocure granted to the Subsidiary an exclusive, sub-licensable, worldwide, license (the “License”) to Ocure’s semi-occlusive wound dressing for ambulatory treatment of acute and chronic anal fissure, pursuant to Ocure’s patents and patent applications (the “Licensed Technology”) and to its production, use, import, offer for sale, sell, lease, distribute, or otherwise commercialize the Licensed Technology for uses classified as medical devices, or those otherwise approved ultimately as an OTC (over-the-counter) remedy. In a further step to exit this line of business due to Madison-IL not achieving the projected development milestones, the Company elected January 4, 2017 to terminate the Ocure License and write off the remaining investment. On April 1, 2017, by consent action of a majority of the Company’s shareholders, Madison Ventures sold Madison-IL, the wholly owned subsidiary, to a shareholder of the Company.

 

Under the License Agreement, the Company was obligated as consideration for the Licensed Technology to provide the Subsidiary $250,000 for the commercialization of the Licensed Technology, payable according to the following schedule:

 

  · $10,000 upon execution of the Letter of Intent (paid February 27, 2015 to Ocure),
  · $90,000 at the later of May 11, 2015 or the final signing date of the License Agreement (the “Effective Date”),
  · $50,000 on or before March 4, 2016, and
  · $100,000 on or before April 8, 2016 (collectively, the “First $250,000 Tranche”).

 

The Effective Date occurred upon satisfaction of the Condition Precedent, as defined in the License Agreement, and approval of the Agreement by the Chief Scientist of the Israeli Ministry of the Economy. The License Agreement Effective Date is November 11, 2015; the date approval of the Chief Scientist of the Israeli Ministry of the Economy was received. Upon the 6-month anniversary of the Effective Date, if the Company had paid the First $250,000 Tranche, then Ocure would have transferred certain assets, as defined, to the Subsidiary, and the Company would be obligated to provide the Subsidiary a second $250,000 tranche, payable as follows:

 

  · $100,000 on or before August 12, 2016,
  · $100,000 on or before September 23, 2016, and
  · $50,000 on or before October 28, 2016.

 

The License Agreement terminated, on a country-by-country basis, the later of: (a) the date of expiration of the last to expire of Ocure’s rights in Ocure Patents in such country or such other grant of statutory exclusivity, or (b) the end of a period of fifteen (15) years from the date of making the first commercial sale, as defined, in such country; unless sooner terminated pursuant to the terms of the License Agreement.

 

Immediately after the Effective Date of the License Agreement and for the period ending March 31, 2016 (as amended), the shareholders of Ocure and certain individuals designated by Ocure had the opportunity to purchase up to an aggregate of 7,100,000 (1,775,000 presplit) shares of the Company’s Common Stock at the par value of $0.001 per share. In addition, the Company was to establish an incentive stock option plan reserving up to 20% of the Company’s issued share capital, as of the closing. The right to purchase an aggregate of 7,100,000 (1,775,000 presplit) shares of the Company’s Common Stock expired unexercised and the Company has not established an incentive stock option plan.

 

In consideration of the license for the Licensed Technology and with respect to any inventions, improvement, development or enhancement based upon, consists of, comprises, contains or incorporates the Licensed Technology invented following the Effective Date by the Subsidiary, its affiliate or sub-licensee (the “New Inventions”), the Subsidiary agreed to pay Ocure royalties calculated as 5% of gross sales. In addition, the Subsidiary agreed to pay Ocure 20% of any cash or non-cash consideration received, whether for sublicense initiation fee, annual fee, sublicense milestone payments, or other such non-sale based royalty consideration payable by a sublicense as consideration for or under a sublicense.

 

The Company was in default of the First $250,000 Tranche aggregate payment due on April 8, 2016. Upon the six month anniversary of the Effective Date (May 11, 2016) no assets were transferred by Ocure to the Company’s subsidiary. As of March 31, 2017, the Company had advanced funds aggregating $221,850 to the Subsidiary and paid Ocure $10,000 under the License Agreement. As such, the Company was in breach of its obligations under the License Agreement, but had not received notice of termination from Ocure. Madison-IL had not achieved the projected development milestones and the Company elected January 4, 2017 to terminate the Ocure License.

 

As of March 31, 2017, the Subsidiary in furtherance of the commercialization of the Licensed Technology has incurred an aggregate of $266,722 of costs recorded as the investment in technology license. At March 31, 2017, the additional costs recorded as the investment in technology license represent vendor obligations payable. In a further step to exit this line of business due to Madison-IL not achieving the projected development milestones, the Company elected January 4, 2017 to terminate the Ocure License and write off the remaining investment. On April 1, 2017, by consent action of a majority of the Company’s shareholders, Madison Ventures sold Madison-IL, the wholly owned subsidiary, to a shareholder of the Company.

 

Accordingly, the investment in the technology license of $266,722, at January 4, 2017, has been written off and recognized as an expense during the year ended March 31, 2017. As of December 31 and March 31, 2017, zero technology license costs are capitalized.

XML 21 R11.htm IDEA: XBRL DOCUMENT v3.10.0.1
Due to related parties
9 Months Ended
Dec. 31, 2017
Notes to Financial Statements  
5. Due to related parties

Due to related parties at December 31 and March 31, 2017 consisted of the following:

 

    December 31,     March 31,  
    2017     2017  
             
Balance at beginning of period   $ 236,942     $ 213,442  
Funds advanced     15,000       23,500  
Funds repaid     (100     -  
Balance at end of period   $ 251,842     $ 236,942  

 

On July 3, July 8, July 10, August 12, November 12, November 13, 2014, January 23, February 27, March 5, May 16, June 17, June 30, July 6, August 13, November 17, 2015, February 13, February 20, March 7 and March 17, 2016, Ecogenics Limited, a shareholder of the Company, advanced the Company $2,000, $775, $1,460, $2,000, $2,000, $1,763, $2,000, $10,000, $3,525, $4,093, $2,755, $1,083, $5,000, $3,000, $2,041, $961, $5,000, $3,300, and $50,000 respectively, as a series of unsecured obligations.

 

On August 11 and November 10, 2016, Pompeii Finance, a shareholder of the Company, advanced the Company $6,500 and $5,250, respectively, as a series of unsecured obligations.

 

On April 1, 2017, by consent action of a majority of the Company’s shareholders, Madison Ventures negotiated the sale of Madison-IL, following the termination of the Ocure License, to Pompeii Finance for $100 which was deducted from the funds owed to Pompeii for the above advances. See Note 7.

 

The net funds aggregating $114,406 were used to pay operating costs of the Company. The aggregate obligations bear no interest, have no fixed term and are not evidenced by any written agreements. The shareholders are under no obligation to advance additional funds to the Company.

 

On December 3, December 24, 2015, January 4, January 6, January 15, November 10, 2016, February 7, March 30, and September 5, 2017, Morpheus Financial Corporation Limited, a shareholder of the Company, advanced the Company $37,473, $7,500, $7,326, $8,412, $49,975, $3,750, $5,000, $3,000, and $15,000, respectively, as a series of unsecured obligations. The funds aggregating $137,436 were used to pay operating costs of the Company. On February 7, and June 19, 2018, Morpheus advanced the Company $20,538 and $1,167, respectively, to pay operating costs of the Company.

 

On January 8, 2016, the aggregate advances received and future advances from Morpheus were structured as a noninterest bearing unsecured non-recourse loan due January 31, 2017. The shareholder, if requested by the Company, agreed to advance additional funds to the Company up to a maximum of $250,000 subject to certain timing limitation as defined. The Company is currently is negotiating an extension of the due date.

XML 22 R12.htm IDEA: XBRL DOCUMENT v3.10.0.1
Long-term debt due to related party
9 Months Ended
Dec. 31, 2017
Notes to Financial Statements  
6. Long-term debt due to related party

Long term debt at December 31 and March 31, 2017 consisted of the following:

 

    December 31,     March 31,  
    2017     2017  
             
Balance at beginning of period   $ 110,000     $ -  
Funds advanced     65       110,000  
Funds repaid     -       -  
Balance at end of period   $ 110,065     $ 110,000  

 

On April 18, 2016, the Company entered into a five year non-interest bearing loan agreement for $110,000 with Cronus Overseas Corporation, a shareholder of the Company. Proceeds were used to fund the Technology acquisition and operations. If the loan is not repaid on or before April 15, 2021 the loan amount will be subject to default interest on the amount then outstanding of ten percent (10%) per month during the first 30 days of delinquency, fifteen percent (15%) per month during the 31 to 60 days of delinquency, twenty percent (20%) per month during the 61 to 90 days of delinquency (the “Default Interest”). If the loan amount remains unpaid after 90 days the lender, at its option, will be entitled to a default payment of one hundred fifty-nine percent (159%) of the then outstanding loan amount inclusive of the Default Interest. On September 25, 2017, Cronus paid on behalf of the Company $65 for operating costs of the Company.

XML 23 R13.htm IDEA: XBRL DOCUMENT v3.10.0.1
Related party transactions
9 Months Ended
Dec. 31, 2017
Notes to Financial Statements  
7. Related party transactions

Employment Agreements

 

On April 2, 2014, Mr. Gene Gregorio was appointed the Company’s President, Chief Executive Officer, Chief Financial Officer and sole Director. On April 20, 2014, the Company agreed to issue Mr. Gregorio 1,000,000 (250,000 presplit) restricted shares of the Company’s Common Stock, valued at $25,000, based on the market close, as compensation for his services for an initial term of one year (the “April 20th Agreement”). On March 31, 2015, the Company issued Mr. Gregorio the agreed 1,000,000 restricted shares of the Company’s Common Stock.

 

In addition, if during the term of the April 20th Agreement Mr. Gregorio’s direct efforts result in a consummated financing for the Company he shall be paid a 5.0% fee on such financing received by the Company, at his option, as either cash or shares of Company’s Common Stock at the offering price. Additionally, the Company will grant Mr. Gregorio a 2 year stock option priced at the current market trading price equal to 5% of the aggregate shares issued to investors within the financing

 

On April 14, 2015, the April 20th Agreement with Mr. Gene Gregorio was extended for a second year under the same terms and conditions. Mr. Gregorio will be issued 1,000,000 restricted shares of the Company’s Common Stock, valued at $25,000, based on the market close, as compensation for his services for the second year the extended April 20th Agreement.

 

On August 9, 2016, the Company issued Mr. Gregorio the agreed 1,000,000 restricted shares of the Company’s Common Stock for services rendered during the period April 21, 2015 to April 20, 2016.

 

On April 23, 2018, Mr. Gregorio resigned as the Company’s President, Chief Executive Officer, Chief Financial Officer and as the sole Director.

 

Madison-IL

 

On March 31, 2017, the Company forgave the intercompany debt between Madison Ventures, Inc. and Madison-IL Ltd which aggregated $231,850. The Company, established Madison-IL on July 9, 2015 as a wholly-owned subsidiary, incorporated under the laws of the country of Israel to address the Company’s requirement for an Israeli company to operate and hold the assets associated with Ocure License. Following the Company’s January 4, 2017 decision to terminate the Ocure License and to dissolve or liquidate Madison-IL, by consent action of a majority of the Company’s shareholders, Madison Ventures negotiated the sale of Madison-IL to Pompeii Finance, a shareholder of the Company, on April 1, 2017 for $100 which was deducted from the funds owed to Pompeii for related party advances. See Note 5. Pompeii assumes the remaining assets and liabilities of Madison-IL which on March 31, 2017 aggregated 23,844 NIL and 250,996 NIL or approximately $6,566 and $69,115, respectively. On April 1, 2017, the Company recognized a net gain from the sale of Madison-IL of $48,911 ($62,549 of net liabilities eliminated, offset by $13,738 of other comprehensive losses from prior period foreign translation adjustments and $100 of proceeds received).

XML 24 R14.htm IDEA: XBRL DOCUMENT v3.10.0.1
Capital stock
9 Months Ended
Dec. 31, 2017
Notes to Financial Statements  
8. Capital stock

The Company’s capitalization is 300,000,000 shares of common stock, with a par value of $0.001 per share, with 29,400,000 shares issued and outstanding at December 31, 2017 and March 31, 2017. On April 11, 2016, the Company effected a four for one forward stock split of our i) authorized and ii) issued and outstanding shares of common stock. All share information has been restated for all periods presented giving retroactive effect of the April 11, 2016 four to one forward stock split. Prior to the forward stock split the Company had 75,000,000 authorized shares of common stock, with a par value of $0.001 per share and 7,100,000 shares issued and outstanding at March 31, 2016.

 

As of March 31, 2017 and 2016, the Company has not granted any stock options or stock warrants.

XML 25 R15.htm IDEA: XBRL DOCUMENT v3.10.0.1
Subsequent Events
9 Months Ended
Dec. 31, 2017
Notes to Financial Statements  
9. Subsequent Events

On February 7, 2018, Morpheus Financial Corporation Limited, a shareholder of the Company, advanced the Company $20,538 (advanced as 25,735 CND) to pay operating costs.

 

On April 23, 2018, the Company entered into a Plan of Reorganization and Agreement of Securities Exchange (the “Agreement”) with Firetainment Inc. (“Firetainment”), a Florida Corporation. The Agreement will result in the merger of Firetainment into Madison Ventures with the corporation to survive as Firetainment Inc. Pursuant to the Agreement the Company agreed to issue Firetainment two hundred million (200,000,000) common shares in exchange for all of the shares of Firetainment. This issuance will result in a change in control of the Company. Under the Agreement, upon execution, Firetainment received the immediate right to the appointment of the directors and officers of the surviving corporation by the resignation of the existing sole director and officer of the Company and the simultaneous appointment of its own designee being the newly appointed sole director and officer. The closing of the Agreement will take place upon the delivery and completion of Firetainment audited statements for the period ending March 31, 2018, unless another time or date, or both, are agreed to in writing by the parties.

 

Also on April 23, 2018, the Board of Directors appointed William Shawn Clark as our Chief Executive Officer, Chief Financial Officer, Secretary and Treasurer as well as our Sole Director. Concurrent with Mr. Clarks’ appointment, Eugenio Gregorio resigned as Chief Executive Officer, Chief Financial Officer, Secretary and Treasurer as well as our Sole Director. Mr. Clark, the sole owner of Firetainment, is now our sole officer and director.

 

On June 19, 2018, Morpheus Financial Corporation Limited, a shareholder of the Company, advanced the Company $1,167 to pay operating costs.

 

On June 29, 2018, Firetainment Inc. advanced the Company $10,000 to pay operating costs.

 

On July 5, 2018, holders of 15,820,000 shares of the Company’s outstanding common stock, representing approximately 53.8% of the outstanding shares, approved, by written consents, an amendment to the articles of incorporation of the Company to change the name of the Company from “Madison Ventures Inc.” to “Viabuilt Ventures Inc.” On July 5, 2018, there were no written consents received by the Company representing a vote against, abstention or broker non-vote with respect to the proposal to change the name. The Company expects to change its name when all regulatory approvals have been obtained.

XML 26 R16.htm IDEA: XBRL DOCUMENT v3.10.0.1
Nature of operations (Policies)
9 Months Ended
Dec. 31, 2017
Nature Of Operations  
Use of Estimates and Assumptions

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods presented. The Company is required to make judgments and estimates about the effect of matters that are inherently uncertain. The Company regularly evaluates estimates and assumptions related to the useful life and recoverability of long-lived assets, deferred income tax asset valuations and loss contingences. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. Although, webelieve our judgments and estimates are appropriate, actual future results may be different; if different assumptions or conditions were to prevail, the results could be materially different from our reported results.

Share-based Compensation

Codification topic 718 “Stock Compensation” requires that the cost resulting from all share-based transactions be recorded in the financial statements and establishes fair value as the measurement objective for share-based payment transactions with employees and acquired goods or services from non-employees. The codification also provides guidance on valuing and expensing these awards, as well as disclosure requirements of these equity arrangements. The Company adopted the codification upon creation of the company and will expense share based costs in the period incurred. The Company has not adopted a stock option plan or completed a share-based transaction; accordingly no stock-based compensation has been recorded to date.

Recent Accounting Pronouncements

The Company’s management has evaluated all the recently issued, but not yet effective, accounting standards that have been issued or proposed by the FASB or other standards-setting bodies through the filing date of these financial statements and does not believe the future adoption of any such pronouncements will have a material effect on the Company’s financial position and results of operations.

XML 27 R17.htm IDEA: XBRL DOCUMENT v3.10.0.1
Due to related parties (Tables)
9 Months Ended
Dec. 31, 2017
Due To Related Parties  
Due to related parties

    December 31,     March 31,  
    2017     2017  
             
Balance at beginning of period   $ 236,942     $ 213,442  
Funds advanced     15,000       23,500  
Funds repaid     (100     -  
Balance at end of period   $ 251,842     $ 236,942  

XML 28 R18.htm IDEA: XBRL DOCUMENT v3.10.0.1
Long-term debt due to related party (Tables)
9 Months Ended
Dec. 31, 2017
Long-term Debt Due To Related Party  
Long term debt

    December 31,     March 31,  
    2017     2017  
             
Balance at beginning of period   $ 110,000     $ -  
Funds advanced     65       110,000  
Funds repaid     -       -  
Balance at end of period   $ 110,065     $ 110,000  

XML 29 R19.htm IDEA: XBRL DOCUMENT v3.10.0.1
Nature of operations (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended 9 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Sep. 30, 2016
Dec. 31, 2017
Dec. 31, 2016
Nature Of Operations Details Narrative          
State of incorporation       State of Nevada  
Date of incorporation       Sep. 14, 2009  
Impairment of technology license $ 12,321 $ 244,904 $ 257,225
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.10.0.1
Going concern (Details Narrative) - USD ($)
Dec. 31, 2017
Mar. 31, 2017
Going Concern    
Accumulated deficit $ (491,096) $ (515,531)
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.10.0.1
Investment in technology license (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Sep. 30, 2016
Dec. 31, 2017
Dec. 31, 2016
Mar. 31, 2017
Mar. 31, 2016
Apr. 08, 2016
Advance for commercialization of the licensed technology           $ 221,850    
Fees paid for commercialization licensed technology           $ 10,000    
Default of the first tranche aggregate payment               $ 250,000
Impairment of technology license $ 12,321 $ 244,904 $ 257,225      
Common stock, par value $ 0.001     $ 0.001   $ 0.001    
Occur royalties payable, percentage       5.00%        
Occur cash payable, percentage       20.00%        
License Agreement One [Member]                
Advance for commercialization of the licensed technology $ 250,000     $ 250,000        
Advance for commercialization of the licensed technology description      

Second $250,000 tranche, payable as follows:

  · $100,000 on or before August 12, 2016,
  · $100,000 on or before September 23, 2016, and
  · $50,000 on or before October 28, 2016.

       
License Agreement [Member]                
Advance for commercialization of the licensed technology $ 250,000     $ 250,000        
Advance for commercialization of the licensed technology description      

Licensed Technology, payable according to the following schedule:

 

  · $10,000 upon execution of the Letter of Intent (paid February 27, 2015 to Ocure),
  · $90,000 at the later of May 11, 2015 or the final signing date of the License Agreement (the “Effective Date”),
  · $50,000 on or before March 4, 2016, and
  · $100,000 on or before April 8, 2016 (collectively, the “First $250,000 Tranche”).
       
Investment in technology license           $ 266,722    
Impairment of technology license           $ 266,722    
Purchase of common stock, shares             7,100,000  
Purchase of common stock, presplit shares             1,775,000  
Common stock, par value             $ 0.001  
Incentive stock option, percentage             20.00%  
Right to purchase of common stock shares, description            

The right to purchase an aggregate of 7,100,000 (1,775,000 presplit) shares of the Company’s Common Stock expired unexercised and the Company has not established an incentive stock option plan.

 
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.10.0.1
Due to related parties (Details) - USD ($)
9 Months Ended 12 Months Ended
Dec. 31, 2017
Mar. 31, 2017
Due To Related Party Details Abstract    
Balance at beginning of period $ 236,942 $ 213,442
Funds advanced 15,000 23,500
Funds repaid (100)
Balance at end of period $ 251,842 $ 236,942
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.10.0.1
Due to related parties (Details Narrative) - USD ($)
9 Months Ended
Dec. 31, 2017
Jun. 19, 2018
Feb. 07, 2018
Sep. 05, 2017
Mar. 31, 2017
Mar. 30, 2017
Feb. 07, 2017
Nov. 10, 2016
Aug. 11, 2016
Mar. 31, 2016
Mar. 17, 2016
Mar. 07, 2016
Feb. 20, 2016
Feb. 13, 2016
Jan. 15, 2016
Jan. 06, 2016
Jan. 04, 2016
Dec. 24, 2015
Dec. 03, 2015
Nov. 17, 2015
Aug. 13, 2015
Jul. 06, 2015
Jun. 30, 2015
Jun. 17, 2015
May 16, 2015
Mar. 05, 2015
Feb. 27, 2015
Jan. 23, 2015
Nov. 13, 2014
Nov. 12, 2014
Aug. 12, 2014
Jul. 10, 2014
Jul. 08, 2014
Jul. 03, 2014
Advance of additional funds, description The shareholder, if requested by the Company, agreed to advance additional funds to the Company up to a maximum of $250,000 subject to certain timing limitation as defined.                                                                  
Due to related party $ 251,842       $ 236,942         $ 213,442                                                
Morpheus Financial Corporation Limited [Member]                                                                    
Due to related party       $ 15,000 $ 137,436 $ 3,000 $ 5,000 $ 3,750             $ 49,975 $ 8,412 $ 7,326 $ 7,500 $ 37,473                              
Morpheus Financial Corporation Limited [Member] | Subsequent Event [Member]                                                                    
Due to related party   $ 1,167 $ 20,538                                                              
Pompeii Finance [Member]                                                                    
Due to related party               $ 5,250 $ 6,500                                                  
Pompeii Finance [Member] | April 1, 2017 [Member]                                                                    
Adjustment of negotiated sale amount 100                                                                  
Ecogenics Limited [Member]                                                                    
Due to related party $ 114,406                   $ 50,000 $ 3,300 $ 5,000 $ 961           $ 2,041 $ 3,000 $ 5,000 $ 1,083 $ 2,755 $ 4,093 $ 3,525 $ 10,000 $ 2,000 $ 1,763 $ 2,000 $ 2,000 $ 1,460 $ 775 $ 2,000
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.10.0.1
Long-term debt due to related party (Details) - USD ($)
9 Months Ended 12 Months Ended
Dec. 31, 2017
Mar. 31, 2017
Longterm Debt Details    
Balance at beginning of period $ 110,000
Funds advanced 65 110,000
Funds repaid
Balance at end of period $ 110,065 $ 110,000
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.10.0.1
Long-term debt due to related party (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Sep. 25, 2017
Apr. 18, 2016
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2017
Dec. 31, 2016
Operating costs     $ 10,291 $ 25,390 $ (24,435) $ 314,925
Cronus Overseas Corporation [Member]            
Long-term debt   $ 110,000        
Default interest description  

If the loan is not repaid on or before April 15, 2021 the loan amount will be subject to default interest on the amount then outstanding of ten percent (10%) per month during the first 30 days of delinquency, fifteen percent (15%) per month during the 31 to 60 days of delinquency, twenty percent (20%) per month during the 61 to 90 days of delinquency (the “Default Interest”). If the loan amount remains unpaid after 90 days the lender, at its option, will be entitled to a default payment of one hundred fifty-nine percent (159%) of the then outstanding loan amount inclusive of the Default Interest.

       
Operating costs $ 65          
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.10.0.1
Related party transactions (Details Narrative) - USD ($)
1 Months Ended 9 Months Ended 12 Months Ended
Aug. 09, 2016
Apr. 14, 2015
Mar. 31, 2015
Apr. 20, 2014
Apr. 20, 2014
Dec. 31, 2017
Mar. 31, 2017
Net liabilities           $ 383,596 $ 430,408
Accumulated other comprehensive income (loss)           (13,738)
Mr. Gene Gregorio [Member]              
Common stock restricted shares   1,000,000 1,000,000 1,000,000      
Common stock restricted shares presplit       250,000      
Value of restricted shares   $ 25,000   $ 25,000      
Stock option investing period description        

In addition, if during the term of the April 20th Agreement Mr. Gregorio’s direct efforts result in a consummated financing for the Company he shall be paid a 5.0% fee on such financing received by the Company, at his option, as either cash or shares of Company’s Common Stock at the offering price. Additionally, the Company will grant Mr. Gregorio a 2 year stock option priced at the current market trading price equal to 5% of the aggregate shares issued to investors within the financing

   
Pompeii Finance [Member] | April 1, 2017 [Member]              
Adjustment of negotiated sale amount           100  
Net liabilities           62,549  
Pompeii Finance [Member] | Madison-IL Ltd [Member]              
Business acquisition remaining assets             6,566
Business acquisition remaining liabilities             69,115
Pompeii Finance [Member] | Madison-IL Ltd [Member] | April 1, 2017 [Member]              
Business combination net gain from sale           48,911  
Accumulated other comprehensive income (loss)           13,378  
Foreign translation adjustments           $ 100  
Madison Ventures, Inc [Member] | Madison-IL Ltd [Member]              
Forgiveness of debt             $ 231,850
Mr. Gregorio [Member]              
Shares issued for service 1,000,000            
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.10.0.1
Capital stock (Details Narrative) - $ / shares
Apr. 11, 2016
Dec. 31, 2017
Mar. 31, 2017
Mar. 31, 2016
Common stock, par value   $ 0.001 $ 0.001  
Common stock, shares authorized   300,000,000 300,000,000  
Common stock, shares issued   29,400,000 29,400,000  
Common stock, shares outstanding   29,400,000 29,400,000  
Forward stock split [Member]        
Common stock, par value       $ 0.001
Common stock, shares authorized       75,000,000
Common stock, shares issued       7,100,000
Common stock, shares outstanding       7,100,000
Forward stock split four for one      
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.10.0.1
Subsequent Event (Details Narrative) - USD ($)
1 Months Ended
Jul. 05, 2018
Apr. 23, 2018
Jun. 29, 2018
Jun. 19, 2018
Feb. 07, 2018
Dec. 31, 2017
Sep. 05, 2017
Mar. 31, 2017
Mar. 30, 2017
Feb. 07, 2017
Nov. 10, 2016
Mar. 31, 2016
Jan. 15, 2016
Jan. 06, 2016
Jan. 04, 2016
Dec. 24, 2015
Dec. 03, 2015
Due to related party           $ 251,842   $ 236,942       $ 213,442          
Common stock, shares outstanding           29,400,000   29,400,000                  
Morpheus Financial Corporation Limited [Member]                                  
Due to related party             $ 15,000 $ 137,436 $ 3,000 $ 5,000 $ 3,750   $ 49,975 $ 8,412 $ 7,326 $ 7,500 $ 37,473
Subsequent Event [Member]                                  
Common stock, shares outstanding 15,820,000                                
Common stock, shares outstanding holding percentage 53.80%                                
Subsequent Event [Member] | Morpheus Financial Corporation Limited [Member]                                  
Due to related party       $ 1,167 $ 20,538                        
Subsequent Event [Member] | Firetainment Inc [Member]                                  
Due to related party     $ 10,000                            
Subsequent Event [Member] | Securities Exchange Agreement [Member] | Firetainment Inc [Member]                                  
Common shares exchange upon execution under agreement   200,000,000                              
EXCEL 39 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 40 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 41 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 43 FilingSummary.xml IDEA: XBRL DOCUMENT 3.10.0.1 html 93 116 1 false 19 0 false 4 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://madisonventures.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - Condensed Consolidated Balance Sheets Sheet http://madisonventures.com/role/BalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://madisonventures.com/role/BalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://madisonventures.com/role/StatementsOfOperations Condensed Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Condensed Consolidated Statements of Changes in Stockholders??? Equity (Deficit) (Unaudited) Sheet http://madisonventures.com/role/StatementsOfChangesInStockholdersEquityDeficit Condensed Consolidated Statements of Changes in Stockholders??? Equity (Deficit) (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://madisonventures.com/role/StatementsOfCashFlows Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - Condensed financial statements Sheet http://madisonventures.com/role/FinancialStatements Condensed financial statements Notes 7 false false R8.htm 00000008 - Disclosure - Nature of operations Sheet http://madisonventures.com/role/NatureOfOperations Nature of operations Notes 8 false false R9.htm 00000009 - Disclosure - Going concern Sheet http://madisonventures.com/role/GoingConcern Going concern Notes 9 false false R10.htm 00000010 - Disclosure - Investment in technology license Sheet http://madisonventures.com/role/InvestmentInTechnologyLicense Investment in technology license Notes 10 false false R11.htm 00000011 - Disclosure - Due to related parties Sheet http://madisonventures.com/role/DueToRelatedParties Due to related parties Notes 11 false false R12.htm 00000012 - Disclosure - Long-term debt due to related party Sheet http://madisonventures.com/role/Long-termDebtDueToRelatedParty Long-term debt due to related party Notes 12 false false R13.htm 00000013 - Disclosure - Related party transactions Sheet http://madisonventures.com/role/RelatedPartyTransactions Related party transactions Notes 13 false false R14.htm 00000014 - Disclosure - Capital stock Sheet http://madisonventures.com/role/CapitalStock Capital stock Notes 14 false false R15.htm 00000015 - Disclosure - Subsequent Events Sheet http://madisonventures.com/role/SubsequentEvents Subsequent Events Notes 15 false false R16.htm 00000016 - Disclosure - Nature of operations (Policies) Sheet http://madisonventures.com/role/NatureOfOperationsPolicies Nature of operations (Policies) Policies 16 false false R17.htm 00000017 - Disclosure - Due to related parties (Tables) Sheet http://madisonventures.com/role/DueToRelatedPartiesTables Due to related parties (Tables) Tables http://madisonventures.com/role/DueToRelatedParties 17 false false R18.htm 00000018 - Disclosure - Long-term debt due to related party (Tables) Sheet http://madisonventures.com/role/Long-termDebtDueToRelatedPartyTables Long-term debt due to related party (Tables) Tables http://madisonventures.com/role/Long-termDebtDueToRelatedParty 18 false false R19.htm 00000019 - Disclosure - Nature of operations (Details Narrative) Sheet http://madisonventures.com/role/NatureOfOperationsDetailsNarrative Nature of operations (Details Narrative) Details http://madisonventures.com/role/NatureOfOperationsPolicies 19 false false R20.htm 00000020 - Disclosure - Going concern (Details Narrative) Sheet http://madisonventures.com/role/GoingConcernDetailsNarrative Going concern (Details Narrative) Details http://madisonventures.com/role/GoingConcern 20 false false R21.htm 00000021 - Disclosure - Investment in technology license (Details Narrative) Sheet http://madisonventures.com/role/InvestmentInTechnologyLicenseDetailsNarrative Investment in technology license (Details Narrative) Details http://madisonventures.com/role/InvestmentInTechnologyLicense 21 false false R22.htm 00000022 - Disclosure - Due to related parties (Details) Sheet http://madisonventures.com/role/DueToRelatedPartiesDetails Due to related parties (Details) Details http://madisonventures.com/role/DueToRelatedPartiesTables 22 false false R23.htm 00000023 - Disclosure - Due to related parties (Details Narrative) Sheet http://madisonventures.com/role/DueToRelatedPartiesDetailsNarrative Due to related parties (Details Narrative) Details http://madisonventures.com/role/DueToRelatedPartiesTables 23 false false R24.htm 00000024 - Disclosure - Long-term debt due to related party (Details) Sheet http://madisonventures.com/role/Long-termDebtDueToRelatedPartyDetails Long-term debt due to related party (Details) Details http://madisonventures.com/role/Long-termDebtDueToRelatedPartyTables 24 false false R25.htm 00000025 - Disclosure - Long-term debt due to related party (Details Narrative) Sheet http://madisonventures.com/role/Long-termDebtDueToRelatedPartyDetailsNarrative Long-term debt due to related party (Details Narrative) Details http://madisonventures.com/role/Long-termDebtDueToRelatedPartyTables 25 false false R26.htm 00000026 - Disclosure - Related party transactions (Details Narrative) Sheet http://madisonventures.com/role/RelatedPartyTransactionsDetailsNarrative Related party transactions (Details Narrative) Details http://madisonventures.com/role/RelatedPartyTransactions 26 false false R27.htm 00000027 - Disclosure - Capital stock (Details Narrative) Sheet http://madisonventures.com/role/CapitalStockDetailsNarrative Capital stock (Details Narrative) Details http://madisonventures.com/role/CapitalStock 27 false false R28.htm 00000028 - Disclosure - Subsequent Event (Details Narrative) Sheet http://madisonventures.com/role/SubsequentEventDetailsNarrative Subsequent Event (Details Narrative) Details http://madisonventures.com/role/SubsequentEvents 28 false false All Reports Book All Reports mdsv-20171231.xml mdsv-20171231.xsd mdsv-20171231_cal.xml mdsv-20171231_def.xml mdsv-20171231_lab.xml mdsv-20171231_pre.xml http://fasb.org/us-gaap/2017-01-31 http://xbrl.sec.gov/dei/2014-01-31 http://xbrl.sec.gov/invest/2013-01-31 true true ZIP 45 0001477932-18-003689-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001477932-18-003689-xbrl.zip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